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Metabolic syndrome and cognitive 
decline are common health problems 
in Western population. Before one 
can devise strategies to avoid the 
metabolic syndrome and maintain 
good cognitive function, it is essen-
tial to identify modifiable lifestyle 
factors associated with both con-
ditions. In the present thesis, the 
associations of dietary factors and 
cardiorespiratory fitness with the 
metabolic syndrome and cognitive 
function were examined in a repre-
sentative population-based sample of 
older Finnish men and women. 
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ABSTRACT 
 
Metabolic syndrome and cognitive decline are common health problems in Western 
population. Both of these conditions are related to a larger cluster of different risk factors. 
Metabolic syndrome increases the risk of type 2 diabetes and cardiovascular diseases, which 
are known risk factors for dementia. The aim of the present dissertation was to study the 
associations between diet and cardiorespiratory fitness with the risk of suffering from the 
metabolic syndrome and experiencing a decline in cognitive function among 57-78 years old 
men and women in Eastern Finland. This study was part of the population-based DR's 
EXTRA –intervention study. 
Altogether 1410 individuals participated in this study. Based on a four-day food record, 
the consumption of food items and intake of nutrients as well as the subject’s diet’s similarity 
to two healthy dietary patterns were calculated. Cardiorespiratory fitness was assessed as 
maximal oxygen uptake (VO2max, ml/kg/min) by a respiratory gas analysis in a maximal 
symptom-limited exercise stress test on a cycle ergometer. The metabolic syndrome was 
defined according to the National Cholesterol Education Program -criteria. Cognitive 
function was assessed by the Consortium to Establish a Registry for Alzheimer’s Disease 
(CERAD) and the Mini-Mental State Examination (MMSE) neuropsychological test batteries. 
High consumptions of berries, fish, legumes and nuts were associated with a lower risk of 
having metabolic syndrome in men, whereas in women, a high consumption of sausage was 
associated with a higher risk. In addition, adherence to a healthy diet in line with Finnish 
nutrition recommendations and good cardiorespiratory fitness were independently 
associated with a lower risk of having metabolic syndrome. The risk was lowest among those 
individuals in the highest tertile of cardiorespiratory fitness and achieving 3-4 dietary goals 
out of 4. On the other hand, the highest risk of having metabolic syndrome was observed 
among those individuals in the lowest tertile of cardiorespiratory fitness who did not reach 
any of the dietary goals. 
The baseline Nordic diet score was positively associated with the CERAD total score in 
women and MMSE in men at four years; both scales assess the global cognitive function. 
Furthermore, in women, the baseline Nordic diet score was positively associated with two 
subtests in the CERAD test battery - the Word list learning and Word List Recall, at four 
years. 
These results emphasize that middle-aged and elderly individuals should adopt a healthy 
diet in line with existing guidelines and strive for good cardiorespiratory fitness as ways of 
avoiding the metabolic syndrome and maintaining their cognitive function. 
 
National Library of Medicine Classification: QT 235, QT 256, WL 141.5.N46, WG 141.5.F9 
Medical Subject Headings: Diet; Oxygen consumption; Motor activity; Metabolic syndrome X; Mild cognitive 
impairment; Neuropsychological tests; Middle Aged; Aged 
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TIIVISTELMÄ 
 
Länsimaisilla aikuisilla metabolinen oireyhtymä ja heikentynyt kognitiivinen toimintakyky 
ovat yleisiä terveysongelmia. Molemmat tilat liittyvät laajempaan riskitekijöiden 
ryppääseen, sillä metabolinen oireyhtymä lisää tyypin 2 diabeteksen sekä sydän- ja 
verisuonisairauksien riskiä, ja toisaalta näiden sairauksien tiedetään lisäävän dementian 
riskiä. Tämän väitöskirjatyön tarkoituksena oli selvittää ruokavalion ja fyysisen 
suorituskyvyn yhteyttä metabolisen oireyhtymän esiintyvyyteen sekä kognitiivisen 
toimintakyvyn muutokseen 57-78 -vuotiailla itäsuomalaisilla miehillä ja naisilla osana 
väestöpohjaista DR's EXTRA –elintapainterventiotutkimusta. 
Tutkimukseen osallistui 1410 henkilöä. Ruokavalio kartoitettiin neljän päivän 
ruokapäiväkirjalla. Sen pohjalta arvioitiin ruoka- ja ravintoaineiden saanti sekä kaksi 
ruokavalion terveellisyyttä kuvaavaa kokonaismittaria. Fyysistä suorituskykyä kuvattiin 
maksimaalisella hapenottokyvyllä (VO2max, ml/kg/min), joka mitattiin oirerajoitteisessa 
maksimaalisessa polkupyörä-ergometritestissä. Metabolinen oireyhtymä määriteltiin The 
National Cholesterol Education Program –kriteeristön mukaan. Kognitiivista toimintakykyä 
arvioitiin The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) sekä The 
Mini-Mental State Examination (MMSE) testisarjoilla. 
Runsas marjojen, kalan sekä palkokasvien ja pähkinöiden käyttö olivat yhteydessä 
pienempään metabolisen oireyhtymän riskiin miehillä ja runsas makkaran käyttö 
suurempaan riskiin naisilla tutkimuksen lähtötilanteessa. Lisäksi suomalaisia 
ravitsemussuosituksia vastaava ruokavalio ja hyvä fyysinen suorituskyky olivat itsenäisesti 
yhteydessä pienempään metabolisen oireyhtymän riskiin. Metabolisen oireyhtymän riski oli 
pienin henkilöillä, jotka kuuluivat parhaaseen fyysisen suorituskyvyn kolmannekseen ja 
saavuttivat 3-4 ravitsemussuositusten mukaista tavoitetta neljästä mahdollisesta. Korkein 
riski puolestaan oli niillä, jotka kuuluivat matalimpaan suorituskyvyn kolmannekseen 
eivätkä saavuttaneet yhtään ravitsemustavoitetta. 
Mitä paremmin naisten ruokavalio vastasi Itämeren ruokavaliota tutkimuksen alussa, sitä 
paremmin he suoriutuivat uuden tiedon oppimista ja muistia arvioivissa tehtävissä sekä 
saavuttivat korkemmat pisteet yleistä kognitiivista toimintakykyä kuvaavassa CERAD-
tehtäväsarjan yhteispistemäärässä. Vastaavasti miehillä Itämeren ruokavalio oli yhteydessä 
parempaan suoriutumiseen MMSE-tehtäväsarjassa neljän vuoden kohdalla.  
Tulokset tukevat suositusten mukaisen ruokavalion ja hyvän fyysisen suorituskyvyn 
merkitystä metabolisen oireyhtymän hallinnassa ja kognitiivisen toimintakyvyn 
ylläpitämisessä keski-ikäisillä ja ikääntyneillä henkilöillä. 
 
Luokitus: QT 235, QT 256, WL 141.5.N46, WG 141.5.F9 
Yleinen Suomalainen asiasanasto: ruokavaliot; maksimaalinen hapenotto; fyysinen aktiivisuus; metabolinen 
oireyhtymä; kognitio; keski-ikäiset; ikääntyneet 
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 1 Introduction  
The proportion of aged people is increasing; it is estimated that from 2012 to 2050 not only will 
the proportion of individuals over 60 years double from 11% to 22% (1) but also four times more 
men and women will celebrate their eightieth birthday in 2050 than managed this feat in 2012.   
This increase in longevity together with the obesity epidemic (2) predisposes more and more 
people to chronic diseases. A cluster of several cardiovascular risk factors, collectively called the 
metabolic syndrome, is a reality today for one third of the adult populations in Europe and the 
United States (3-5). The metabolic syndrome markedly increases the risk of cardiovascular 
diseases (6) and type 2 diabetes (7,8), and may further lead to other diseases such as dementia 
(9,10) and even to a premature mortality (6). This continuum of diseases and their devastating 
effect on health explaines why the metabolic syndrome is such a serious public health problem. 
Dementia is one of the most rapidly increasing age-related diseases all around the world (11). 
The prevalence of dementia among individuals of age 60 or over varies from 5 to 7% in different 
countries (12). It is estimated that number of people suffering from dementia is almost doubling 
every 20 years being 36 million worldwide in 2010 and increasing up to 115 million in 2050 (12). 
In Finland, 13 000 individuals are given a dementia diagnosis every year (13). Chronic diseases 
are a burden not only for the patient and his/her family but also to the entire society. The 
economic costs associated with these diseases are enormous and dramatically rising along the 
increased number of patients. For example, worldwide costs for dementia were thought to be 
around 562 billion euros in 2010 (14). In Europe, the annual total cost is estimated to be 22 000€ 
per dementia-patient (15). Therefore, actions to support healthy ageing by preventing and 
delaying the onset of dementia are needed all over the world. 
The risk of developing both the metabolic syndrome and dementia are determined by the 
genes, the lifestyle and environment across the life course (Figure 1) and of these, lifestyle is the 
factor that can be most readily modified. Even though genes are considered as non-modifiable 
factors, both lifestyle and environment interact with genes affecting their up- and 
downregulation. Thus, it matters what we eat, how physically active we are, do we smoke and 
what kind of social network we have. Data from randomized controlled trials have demontrated 
that type 2 diabetes can be prevented or the onset of the disease can be delayed by changing the 
diet and physical activity of high risk patients (16,17). While type 2 diabetes and cardiovascular 
diseases are known risk factors for dementia, it seems reasonable to speculate that cognitive 
problems can be prevented with the same lifestyle factors. In fact, recent data has emphasized the 
beneficial impact of a healthy diet (18,19) and regular physical activity (20,21) on cognitive 
function. However, these data are still limited and studies have been conducted mainly among 
high risk patients and therefore the knowledge cannot directly be generalized to whole 
population.  
In the present thesis the associations of a healthy diet and cardiorespiratory fitness with the 
metabolic syndrome and cognitive function were studied among a representative population 
based sample of older Finnish men and women. First, both the independent and combined 
associations of diet and cardiorespiratory fitness with the risk of having the metabolic syndrome 
were the focus of interest. Single food items as well a simple dietary score were used to describe 
the diet. Subsequently, it was decided to evaluate the association of the Nordic diet, a typical 
healthy dietary pattern in Nordic countries, with the cognitive function.  
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2  Review of the literature 
In the review of the literature, the role of diet, physical activity and cardiorespiratory fitness on 
the metabolic syndrome and cognitive function will be presented focusing on middle-aged and 
elderly individuals. To provide a background to this review, the frequently repeated terminology 
will be defined herein. 
In recent years, research into the metabolic syndrome and cognition has focused on the effects 
of dietary patterns, rather than single nutrients or food items. Dietary patterns describe the diet 
as a whole, representing the concept that food items and/or nutrients interact with each other. 
Most of the studies have examined the Mediterranean diet which is characterized by a high 
consumption of plant foods (vegetables, fruit, legumes, cereals, nuts and seeds), moderate 
consumption of fish and dairy products (mainly cheese and yogurt), relatively low consumption 
of red meat, low to moderate consumption of alcohol (normally with meals) with olive oil as the 
principal source of fat (22). Another interesting and well-studied dietary pattern is the Dietary 
Approaches to Stop Hypertension (DASH) diet, which is rich in fruit, vegetables, and low-fat 
dairy products and low in saturated and total fat and added sugar (23). However, it is also 
important to study the effect of single food items and nutrients on health in order to clarify the 
mechanisms by which diet can influence health.  
Physical activity and cardiorespiratory fitness are clearly associated. Physical activity, 
especially at moderate and vigorous intensity, is an important determinant of cardiorespiratory 
fitness (24,25). However, other factors such as age, gender and genes also exert a major impact 
(26-28). The decline in cardiorespiratory fitness, expressed as maximal oxygen uptake (VO2max, 
ml/kg/min) is approximately 10% per decade in middle-aged and elderly individuals (27,28). In 
addition, women have 20% lower VO2max than men. It is estimated that the heritability of VO2max 
ranges from 25 to 65% (26). In addition, there is extensive heterogeneity in the responsiveness to 
exercise training, e.g. the VO2max response to endurance training varies between individuals, 
reflecting the role of genetic diversity. 
 
2.1 METABOLIC SYNDROME 
2.1.1 Definition of metabolic syndrome  
The metabolic syndrome is a cluster of cardiovascular risk factors including abdominal obesity, 
dyslipidemia, elevated blood pressure, insulin resistance and glucose intolerance (29). The 
metabolic syndrome is an important factor in identifying those high risk patients who will 
develop type 2 diabetes (7,8) or atherosclerotic cardiovascular disease (6). Individuals with the 
metabolic syndrome have a two- and five-fold increased risk to develop cardiovascular disease 
or type 2 diabetes, respectively, during next five to ten years compared to those without the 
syndrome (30). In individuals with cardiovascular disease or diabetes, the metabolic syndrome 
is often present, and the number of its individual components predicts the disease progression. 
In the literature, the metabolic syndrome has also been known as syndrome X (31) and insulin 
resistance syndrome (32). The first standardized criterion was published by WHO in 1998 (33). 
Subsequently, several definitions have been published (see Table 1 in Appendices). New criteria 
have been developed to improve the clinical utility of the earlier definitions. While the latest 
criteria agree on the value of majority of the components, there is still a gap in the knowledge to 
define accurate thresholds for abdominal obesity (30). More data are still needed about the 
relation between waist circumference thresholds and the other metabolic risk factors, 
cardiovascular diseases and type 2 diabetes in both genders and in different ethnic groups.  
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2.1.2 Pathophysiology and management of metabolic syndrome 
Abdominal obesity and insulin resistance are believed to be the primary causes of the metabolic 
syndrome (30). It has been claimed that, abdominal obesity may be the driving force to develop 
insulin resistance (34).  
In overweight and obesity, excess fat accumulates in the body, in subcutaneous, visceral or 
ectopic sites (35). However, rather than the total amount of fat, it seems to be the location of the 
excess fat which is the more important determinant of health problems related to overweight and 
obesity (36). In metabolically healthy obese individuals, excess fat is accumulated into the 
subcutaneous adipose tissue (35). However, a dysfunctional subcutaneous adipose tissue is 
unable to store excess energy, thus lipids overflow into other organs into visceral and ectopic 
sites. In abdominal obesity, excess fat gathers in the abdominal cavity around the internal organs, 
and is called visceral fat. Excess fat accumulates also in the ectopic sites such as the liver (34), 
skeletal muscles (34) and pancreas (37). It has been postulated that ectopic fat accumulation 
causes insulin resistance in adipose tissue, skeletal muscles and liver, further disrupting 
metabolism (34). In addition, visceral adiposity is associated with more cardiovascular risk 
factors compared to subcutaneous adiposity (35,38). 
Insulin resistance in the skeletal muscle changes the pattern of energy storage from ingested 
carbohydrates away from skeletal muscle glycogen synthesis into lipogenesis in the liver, thus, 
resulting in dyslipidemia and hepatic lipid accumulation (39). It still remains unclear whether 
liver insulin resistance promotes hepatic lipid accumulation or whether it is lipid accumulation 
within the liver which initiates insulin resistance (34). On the other hand, fat accumulation in the 
pancreas ultimately disrupts secretion of insulin (37). In insulin resistance elevated insulin 
secretion from pancreas is needed to maintain normal blood glucose levels. Over time, insulin 
secretion starts todecline and fails to compensate for the insulin resistance which leads to 
hyperglycaemia and eventually type 2 diabetes (40). Individuals with insulin resistance are more 
vulnerable to develop other features of the metabolic syndrome such as hypertension (41), 
glucose intolerance (i.e. impaired fasting glucose and impaired glucose tolerance) and 
dyslipidemia (i.e. hypertriglyceridaemia, reduced HDL-cholesterol concentration) (34). 
Adipose tissue, especially visceral fat, is an active endocrine organ which produces several 
bioactive compounds known as adipokines e.g. leptin and resistin (42). In addition, adipose tissue 
can become infiltrated by macrophages which release cytokines e.g. tumour necrosis factor-α and 
interleukin-6. These compounds promote insulin resistance and evoke a systemic inflammation 
which are both present in the metabolic syndrome (43) and playing important roles in the 
progression to type 2 diabetes and cardiovascular diseases (42). 
Lifestyle modification is the primary therapy for the management of the metabolic syndrome 
(29,44,45). The most important lifestyle change is a moderate weight reduction (i.e. 5-10% during 
the first year) achieved by adopting an appropriate diet and increased physical activity. Weight 
reduction improves all components of the metabolic syndrome. In order to maintain these 
reductions, it is essential that the individual manages to stay at the lowered body weight. In 
addition, specific changes in lifestyle are recommended in the management of other components 
of the metabolic syndrome. If lifestyle modification does not lead to sufficient results or the 
individual is at a high risk of cardiovascular disease, then medications may be needed. 
 
2.1.3 Diet and metabolic syndrome 
Dietary patterns and metabolic syndrome 
In prospective cohort studies among middle-aged and elderly individuals a good adherence to 
either the DASH diet (46) or the Mediterranean diet (47,48) has been associated with a lower 
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incidence of the metabolic syndrome in comparison to poor adherence (Table 1). In addition, the 
Pro-Vegetarian Diet , i.e. a diet favoring plant foods over animal products has been associated 
with a lower risk of developing the metabolic syndrome in women, but not in men (46). In that 
same study, three different Mediterranean type diet scores were not associated with the metabolic 
syndrome. In contrast, an unhealthy Western dietary pattern, characterized by high consumption 
of refined grains, processed meat, fried foods and red meat was associated with the increased 
incidence of the metabolic syndrome in a prospective cohort study (49). 
Two intervention studies demonstrated that one could achieve a reduction in the prevalence 
of the metabolic syndrome with the DASH diet (50) and with the Mediterranean diet (51), both 
conducted in middle-aged men and women with the metabolic syndrome. Another intervention 
study, revealed a higher reversal rate from the metabolic syndrome in subjects consuming a 
Mediterranean diet supplemented with nuts or with olive oil compared to a control diet (52). 
However, half of the participants without the metabolic syndrome at baseline developed it during 
three years follow-up in all three study groups. Interestingly, the effect of both intervention diets 
on the reversion rate was independent of any body weight change while weight remained stable 
in all of the study groups. In contrast, in other two intervention studies, weight reduction did 
occur and may at least partly explain the associations detected (50,51). All three intervention 
studies were carried out in individuals at high risk for cardiovascular diseases, thus, these results 
cannot be extrapolated to the general population. 
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Single food items, nutrients and metabolic syndrome 
Recently, both the general public and researchers have become interested in the concept of 
modifying the proportions of energy nutrients and their relation to health, especially how this 
can help in weight management, cardiovascular diseases and type 2 diabetes (55,56). Earlier, the 
emphasis was placed on the amount of carbohydrates, total fat and protein, but nowadays the 
quality of these macronutrients is considered as equally, if not more, important. Data from 
prospective studies have shown that whole grains (57,58) and fruit and vegetables (59-63) as the 
sources of carbohydrates are beneficial for the prevention of type 2 diabetes and cardiovascular 
risk. On the other hand, refined grains (58) and added sugar (64-66) are associated with 
unfavourable effects on health. In other words, food items rich in dietary fiber (67) and 
micronutrients as well as with low glycemic index and glycemic load (68) are effective in the 
prevention of type 2 diabetes and cardiovascular diseases.  
There is much less data available on the effects of food items and nutrients on the metabolic 
syndrome itself. Only one cross-sectional (69) and one prospective cohort study (49) with 
contradictory findings have been published regarding fruit and vegetables. In cross-sectional 
studies, the consumption of whole-grains was inversely associated (70-72) whereas the 
consumption of refined-grains was positively linked (71,72) with the risk of having the metabolic 
syndrome. Attempts to detect associations between dietary fiber and the metabolic syndrome 
have proved difficult and the results are partly and conflicting. One prospective observational 
study detected an inverse association between fiber intake from fruits and incidence of the 
metabolic syndrome, whereas fiber intakes from cereals, vegetables, legumes or nuts were not 
associated with the metabolic syndrome (73). In contrast, in two cross-sectional studies, the intake 
of cereal fiber was associated with the metabolic syndrome risk (70,74). 
The quality of dietary fat has an effect on plasma/serum lipid profile and cardiovascular 
disease risk (75). A systematic review of nine randomized controlled trials concluded that there 
was convincing evidence that substituting MUFA and/or PUFA for SFA could lower the fasting 
concentrations of total- and LDL-cholesterol whereas it did not seem to exert any effect on the 
triacylglycerol concentration (75). Furthermore, the evidence for a decreased risk of 
cardiovascular diseases by replacement of SFA with an equivalent amount of PUFA was 
considered as convincing. In addition, a diet rich in MUFA has resulted better insulin sensitivity 
compared to a diet rich in SFA (76). The data of the role of dietary fat in relation to the metabolic 
syndrome seem to be limited to cross-sectional studies. Harmful effect of SFA (77) and total fat 
(78), as well as beneficial effect of linoleic acid (78) have been reported. Interestingly, the source 
of SFA may modify the cardiovascular risk (79). In a large 10-year follow-up study the SFA from 
meat was found to increase the risk of cardiovascular disease whereas the SFA from dairy 
products reduced the risk.   
At the level of distinct foodstuffs, a high consumption of red meat has been associated with an 
increased risk of the metabolic syndrome (49,80,81), type 2 diabetes (82,83) and cardiovascular 
diseases (84,85). Conversely, consumption of dairy products has been beneficially associated with 
the risk of having the metabolic syndrome in the cross-sectional (74,86) and in most of the 
prospective observational (49,87) studies, but not in all (88). Although dairy products are a 
heterogenic group of different type of foods, these studies have estimated dairy as total 
consumption. Although mainly the consumption of milk, cheese and yogurt has been estimated, 
in some studies ice-cream and dairy desserts were included as well. Dairy products are a wide 
range of foodstuffs (e.g. milk, fermented-milk products, cheese, ice-cream) with highly variable 
amounts of SFA (low- and high-fat) and some of them have added sugar (e.g. ice-cream and some 
yogurts). Thus, the health effects of some of these products may well differ from the others. 
High fish consumption has been associated with a lower risk of the metabolic syndrome in 
cross-sectional (74,89) and prospective (90) studies. With regard to the incidence of type 2 
diabetes, a beneficial association has been found for lean (91,92), fatty (91,93) and total (91) fish 
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consumption. In addition, a beneficial association between fish consumption and the risk of 
cardiovascular disease has been observed (94).  
Frequent consumption of nuts is associated with a lower incidence (95) and prevalence (96-98) 
of the metabolic syndrome. Despite their high content of energy and fat, frequent nut 
consumption does not seem to lead to weight gain or increased waist circumference (99).  
Studies examining the association of single food items with the metabolic syndrome have been 
restricted to cross-sectional and prospective studies and no randomized controlled trials have 
been conducted so far. The published trials have been rather heterogenic in that there  have been 
clear differences in study design (e.g. follow-up time, inclusion and exclusion criteria), control of 
confounding factors, definition of the metabolic syndrome and dietary assessment methods used 
(mostly food frequency questionnaires). In addition, food groups are heterogenic while different 
foods are gathered into one group even though their effect on health may be different.  
 
2.1.4 Physical activity, cardiorespiratory fitness and metabolic syndrome 
 
Prospective observational studies have consistently shown that physical activity (100,101) and 
good cardiorespiratory fitness (100,102,103) protect against the metabolic syndrome (Table 2). 
Estimated physical activity energy expenditure in the study of Ekelund et al. included all physical 
activities above resting energy expenditure (101). In the study of Laaksonen et al. the increased 
amounts of moderate and vigorous physical activities were associated with a lower risk of 
developing the metabolic syndrome (100). However, total and low-intensity physical activities 
were not associated with the metabolic syndrome. Better muscular strength has also associated 
with a lower risk of developing the metabolic syndrome independent of age and body size (104). 
In some studies low cardiorespiratory fitness has even been proposed to be one feature of the 
metabolic syndrome (105,106). 
Only a few randomized controlled trials have explored the effect of physical activity on 
presence of the metabolic syndrome (107-109) and all of these have been conducted in sedentary 
middle-aged individuals. A six month trial showed that aerobic physical activity corresponding 
to current guidelines (110), i.e. walking with moderate intensity approximately for 170 minutes 
per week, had a beneficial effect on metabolic syndrome (107). However, increased amounts and 
intensities of exercise provided more benefit. A small study among postmenospausal women 
observed a beneficial effect of resistance training on the metabolic syndrome (108). In contrast, 
resistance training exerted no effect on the prevalence of the metabolic syndrome in individuals 
with type 2 diabetes (109). However, in another trial, aerobic exercise alone and combined with 
resistance exercise resulted in decreased prevalence of the metabolic syndrome. Furthermore, in 
an uncontrolled intervention study with supervised aerobic exercise program three times of 30-
50 minutes per week for 20 weeks decreased the prevalence of the metabolic syndrome (111). 
Most importantly, every third of those individuals who had had the metabolic syndrome at 
baseline were no longer classified as having the syndrome after exercise training. 
In addition to the amount of physical activity, the time spent in a sitting position has been 
reported to increase the risk of developing the metabolic syndrome (112,113). This is the case even 
in individuals who are physically active (113).  These data are limited to cross-sectional studies. 
A prospective observational study showed that replacement of sitting time with exercise or non-
exercise activities (e.g. household tasks and gardening) decreased the all-cause and 
cardiovascular mortality in middle-aged and older individuals (114). 
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2.1.5 Combination of diet and physical activity and metabolic syndrome 
Lifestyle interventions have consistently revealed the beneficial effects of the combination of a 
healthy diet and regular physical activity on the prevalence, incidence and reversion of the 
metabolic syndrome (Table 3) (115-119). All of these studies have been conducted in high risk 
patients with impaired glucose tolerance or metabolic abnormalities.  
Only one intervention study has reported effects of either diet or physical activity on their own 
and in combination on metabolic syndrome (116). In the 1-year intervention study conducted in 
middle-aged men with metabolic syndrome, the combination of diet and physical activity was 
the most effective way to reduce the prevalence of metabolic syndrome. In addition, the 
prevalence of metabolic syndrome was significantly reduced in the diet alone group compared 
to the control group whereas the exercise alone group did not differ from controls. In a 
prospective study involving elderly men and women with the metabolic syndrome, a good 
adherence to a healty diet and regular physical activity at baseline were both independently 
associated with a greater reduction in the metabolic syndrome score during the 6-year follow-up 
(120). However, adherence to both healthy diet and high physical activity level did not confer 
any additional benefit compared to good adherence to either one on its own.  
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2.1.6 Other factors and metabolic syndrome  
The prevalence of the metabolic syndrome increases with age (3,4,121). A cross-sectional analysis 
of over ten thousand participants detected a consistent increment in prevalence of the metabolic 
syndrome from 10% at 20-29 years of age to approximately 50% at 80-89 years of age (121). The 
prevalence of the metabolic syndrome is higher in middle-aged men than in women whereas 
after the age of 60, the prevalence is higher in women than in men (3,121). 
Low birthweight (122) and a pronounced weight increase during early adulthood (123) are 
associated with a higher risk of the metabolic syndrome. This phenomenon has been explained 
by the so-called thrifty phenotype hypothesis (124). Malnutrition during fetal period evokes 
permanent adaptive changes in metabolism and endocrine function, leading to the appearance of 
metabolic diseases later in life. 
Genes also play a role in the metabolic syndrome. The heritability is estimated to be 40-55% 
for abdominal obesity, 10-75% for fasting glucose, 25-60% for triacylglycerols, 30-88% for HDL-
cholesterol and 50% for hypertension (125). The thrifty genes hypothesis is based on the concept 
that genetic selection has favoured energy-conserving genotypes in an environment with an 
unreliable food supply (124). Storage of energy as fat rather than as glycogen would ensure the 
availability of energy during starvation. Unfortunately, nowadays this kind of genotype is 
deleterious, especially in the developed countries where the oversupply of food is evident. 
 
2.2 COGNITIVE FUNCTION 
2.2.1 Domains of cognitive function 
Cognitive function encompasses several domains (126). However, there has been no consensus 
about how these domains should best be classified and this has hampered the research into 
cognitive decline. Thus, in the fifth edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-V) six main domains were outlined for the purpose of classifying neurocognitive 
disorders (Figure 2) (127). These six main domains are learning and memory, executive functions, 
complex attention, language, perceptual-motor function and social cognition. Each domain is 
further divided into subdomains. It is important to note that these cognitive domains overlap 
with each other, thus it is difficult to make a clear differentiation. In practice, successful 
performance in cognitive tasks requires the involvement of several brain structures and functions 
working seamlessly together.  
 
2.2.2 From normal cognition to dementia 
There is no distinct line between normal ageing and cognitive impairment, therefore changes in 
cognition from normal functioning to dementia are usually portrayed as a continuum (128). Most 
individuals experience a gradual decline in cognitive function, usually in memory, during normal 
ageing but this does not affect their daily functioning (129). In older age, vascular and 
degenerative pathologies occur in the brain, and they increase the likelihood of cognitive 
impairment and dementia (130). In fact, these processes appear years, even decades, before the 
clinical onset of dementia (128). During this preclinical state some functional and structural 
alterations occures in the brain but the cognitive function remains normal.  
The intermediate state between normal cognition and dementia is called mild cognitive 
impairment which in some individuals progresses to dementia whereas some others remain 
stable or even return to the normal state (131). In mild cognitive impairment, the cognitive decline 
is evident but its severity does not meet the criteria for dementia, and there are no or only minimal 
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impairments in functional activities (131). Mild cognitive impairment is divided into amnestic 
and nonamnestic subtypes (129).  
In dementia, the cognitive decline is worse than in mild cognitive impairment and is so severe 
that it impacts on the individualʼs ability to perform many daily activities leading to loss of 
independence (130,132,133). The most common forms of dementia are Alzheimerʼs disease (132) 
and vascular dementia (130,133), which actually share some pathological features (130,134). There 
are also other forms of dementia e.g. dementia with Lewy bodies (135), frontotemporal dementia 
(136) and Parkinsonʼs disease with dementia (135).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Neurocognitive domains and their subdomains according to the Diagnostic and Statistical 
Manual of Mental Disorders 5th edition (127).  
Neuro-
cognitive 
domains 
Perceptual – motor 
function 
Visual perception 
Visuoconstructional 
reasoning 
Perceptual-motor 
coordination 
Language 
Object naming 
Word finding 
Fluency 
Grammar and syntax 
Receptive language 
Learning and 
memory 
Free and cued recall 
Recognition memory 
Semantic and 
autobiographical long-
term memory 
Implicit learning 
 
Social cognition 
Recognition of motions 
Theory of mind 
Insight 
Complex attention 
Sustained attention 
Divided attention 
Selective attention 
Processing speed 
Executive 
function 
Planning 
Decision-making 
Working memory 
Responding to 
feedback 
Inhibition 
Flexibility 
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2.2.3 Diet and cognitive function 
 
Dietary patterns and cognitive function 
Several observational prospective studies have explored the effect of specific dietary patterns, 
mainly the Mediterranean diet, on cognitive function (Table 4). In some of these studies the 
Mediterranean diet has been shown to decrease the risk of cognitive decline (137-139), mild 
cognitive impairment (140), the progression from mild cognitive impairment to Alzheimerʼs 
disease (140) and Alzheimerʼs disease (141). However, not all studies have detected associations 
(137,142-145). Only a few studies have been conducted in the actual Mediterranean area (137,142) 
most studies originate from the United States. In the studies conducted in the Mediterranean 
population, consumption of the typical diet of that area has not been associated with cognitive 
function. However, in a secondary analyses of a randomized trial conducted in Spain, the 
Mediterranean diet supplemented with extra virgin olive oil or nuts was associated with better 
cognitive function compared to a control diet (19). One limitation of this trial was that cognitive 
function was assessed only at the end of the intervention. However, in a substudy of the trial, 
neuropsychological tests had been performed both at baseline and after the intervention (146). 
The study revealed that composite scores of memory, frontal and global cognition had improved 
in the intervention groups whereas scores declined in the control group. These findings indicate 
that the Mediterranean diet probably exerted a beneficial effect on cognitive function during 
ageing. 
The DASH –diet, which is rich in fruit, vegetables, and low-fat dairy products and low in SFA 
and total fat (23), was similarly associated with better cognitive function among elderly 
individuals similar to the Mediterranean type diet (139). In a 4-month randomized controlled trial 
the DASH diet alone and combined with aerobic exercise and caloric restriction improved 
neurocognitive function compared with usual diet among overweight and obese prehypertensive 
and hypertensive individuals (18). Other dietary patterns have been shown to lower the risk of 
cognitive decline (147,148), dementia (149,150) and Alzheimerʼs disease (149-151), with follow-
up times varying from 3 (148) to 15 years (150). 
All of these dietary patterns mentioned above place an emphasis on the high consumption of 
vegetables and fruit. In addition, most, but not all, include a high consumption of fish and whole 
grain products and low to moderate consumption of meat and high-fat dairy products. Dietary 
patterns have differed in their definitions of dietary fat quality but the tendency has been to 
favour MUFA and PUFA instead of SFA. Since the adherence to dietary patterns is usually 
estimated with population-based cut point values (e.g. medians), even the same dietary pattern 
is not directly comparable in different countries and populations. In addition, a diet consisting of 
local and familiar food items is easier to adopt than some other diet with foreign food items. 
Therefore one would expect the practical effectiveness of health promotion to be improved if one 
could recommend some kind of local and familiar dietary pattern. 
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Single food items and cognitive function 
Most of the prospective studies have found a protective association for the consumption of 
vegetables with cognitive function (154-156) and dementia (143,157,158), although this positive 
relationship has not been confirmed in all reports (159). None of the studies has found such 
associations for consumption of fruit alone (154-156). However, consumption of berries, 
specifically blueberries and strawberries, was associated with a lower cognitive decline among 
women over aged 70 years in the Nurseʼs Health Study (160).  
In most of the prospective studies high consumption of fish has been associated with lower 
risk of age-related cognitive decline (161-163) and Alzheimerʼs disease (157,164-166) but again 
there are some contradictory reports (142,167). Consumption of whole grain products (139,145), 
nuts and legumes (139) and coffee drinking (168,169) has also been assessed as protective factors 
for cognitive function or against dementia but consumption of meat has not been associated with 
the risk of dementia (157,164). However, these data are rather inconclusive for example, some 
contradictory findings exist regarding coffee drinking (170) and consumption of nuts (156), and 
the number of studies is limited. 
The relationship between alcohol consumption and cognitive function seems to be U- or J-
shaped. Both excessive (171) and binge drinking (172) have been associated with a faster cognitive 
decline in comparison to mild-to-moderate drinking. On the other hand modest alcohol 
consumption may even decrease the risk of cognitive decline (173). 
To conclude, studies examining the association of single food items with cognition are 
restricted to prospective studies; randomized controlled trials do not exist so far. The results from 
these prospective studies are more or less heterogenous and any conclusions must be drawn with 
caution. The inconsistent and occasionally contradictory results are partly explained by 
differences in study design (e.g. follow-up times), control of confounding factors, assessment and 
definition of cognitive function and dementia and dietary assessment methods. In addition, in 
longitudinal studies, the possibility of change in lifestyle (including diet) during the follow-up 
cannot be excluded. By adopting a prospective study design, it is difficult to capture the 
independent effect of a single food item or nutrient on cognition because foods are consumed as 
whole meals, rarely with only one item. Even though the results of the associations between food 
items and cognitive function are inconsistent, there is fair evidence to recommend to consume 
regularly vegetables, fish, whole grain products, legumes and nuts due to their beneficial effects 
on health, particularly since these products do not seem to cause any harmful effects. 
 
Single nutrients and cognitive function 
Antioxidants have been postulated to prevent cognitive decline and dementia due to their ability 
to prevent oxidative damage in cells (174). The main dietary antioxidants are vitamin E, vitamin 
C, carotenoids and polyphenols. A meta-analysis of prospective observational studies concluded 
that dietary intake of vitamin E and vitamin C but not β-carotene may lower the risk of 
Alzheimerʼs disease (175). However, a Cochrane review of randomized controlled trials found 
no evidence that vitamin E supplements exerted no beneficial effects on either Alzheimerʼs 
disease or on the progression from mild cognitive impairment to Alzheimerʼs disease (176). 
Deficiencies in vitamin B12 and folic acid can lead to elevated serum homocysteine levels (177). 
These all have been associated with cognitive function in prospective observational studies; 
serum B vitamins as a protective and homocysteine as a risk factor (178,179). Therefore, the effect 
of supplementation with B vitamins has been evaluated on homocysteine levels and further on 
cognitive function. Two systematic reviews and a meta-analysis of randomized controlled trials 
concluded that supplementation of vitamins B6, B12 and folic acid did not have any beneficial 
effect on cognitive function among healthy or cognitively impaired individuals even though 
homocysteine levels had declined during the supplementation (180-182). However, one subgroup 
of MCI patients with elevated plasma homocysteine levels displayed a slower cognitive decline 
23 
 
 
and a lower rate of brain atrophy after supplementation with B vitamins (B6 20mg/day, B12 0.5 
mg/day and folic acid 0.8 mg/day) compared to the placebo group (183,184).  
Data of the effects of dietary intake of SFA, TFA, MUFA and PUFA on cognition is limited to 
prospective studies, whereas randomized controlled trials have been conducted with omega-3 
fatty acid supplementations (EPA and DHA). Several prospective studies have demonstrated the 
detrimental association between a high intake of SFA with cognitive function (185-187), mild 
cognitive impairment (185) and dementia (188,189) whereas some studies did not detect any 
associations (190-192). In addition, high intake of TFA has been associated with increased risk of 
dementia in one study (188) but not in another (190) and not with cognitive function (187,192). A 
high intake of MUFA has been associated with a lower risk of cognitive decline (186,192) and 
dementia (188) in some, but not all, studies (190,191).  In prospective studies, dietary intake of 
PUFA, especially omega-3 fatty acids, has been associated with a decreased risk of age-related 
cognitive decline (162,163,193) and dementia (189). In addition, low levels of plasma and 
erythrocyte membrane omega-3 fatty acids have been associated with poorer cognitive function 
(194) and higher risk of developing dementia (195). However, data from randomized controlled 
trials is inconsistent. Most of these studies found no effect of omega-3 fatty acid supplementation 
with EPA and/or DHA on cognitive function or dementia in healthy middle-aged and elderly 
(196-198) or in patients with Alzheimerʼs disease (199,200). In contrast, a few studies have 
detected a beneficial effect in healthy individuals (201,202) and in individuals with mild forms of 
cognitive impairment (199,203,204). The findings from randomized controlled trials were 
summarized in a meta-analysis which suggested that omega-3 fatty acids exerted a beneficial 
effect in mild forms of cognitive impairments but not in healthy individuals or in patients with 
Alzheimerʼs disease (205). 
To conclude, while prospective studies have found protective effects of different nutrients, 
such as omega-3 fatty acids, antioxidants and B vitamins, on cognitive decline, most of the 
randomized controlled trials have failed to confirm these associations. This may be due to the fact 
that participants in the clinical trials had already an optimum intake of the nutrient, in which case 
the supplement would have no effect (206). On the other hand, it is possible that a combination 
of different nutrients is needed to obtain the beneficial effect on cognitive function. In support of 
this proposal, a medical nutrient product Souvenaid® containing a combination of nutrients (EPA, 
DHA, phospholipids, choline, uridine monophosphate, selenium, folic acid and vitamins E, C, 
B12 and B6) was claimed to support synapse formation and neuronal function was able to improve 
memory in patients with mild Alzheimerʼs disease (207).  
 
 
2.2.4 Physical activity, cardiorespiratory fitness and cognitive function 
Prospective observational studies have revealed that regular physical activity prevents cognitive 
impairment (208-210) and the risk of dementia (210-212) (Table 5). Regular physical activity 
during the life-time is important in the prevention of late-life cognitive impairment and dementia 
(212,213). However, it is never too late to increase physical activity; the transformation from being 
inactive during the teenage or middle-age years into an active older age can reduce the risk of 
cognitive impairment compared to being inactive during the whole lifetime. It is assumed that 
the beneficial effect of physical activity is at least partly mediated through the improvement in 
cardiorespiratory fitness (214). Actually, prospective observational studies have shown that good 
cardiorespiratory fitness can prevent cognitive impairment (215) and dementia (216). It is 
noteworthy that in only a minority of these studies were the analyses adjusted for diet.  
In most of the randomized controlled trials, aerobic exercise has not proved effective at 
preventing cognitive decline compared to controls (Table 6). However, some studies with a 
higher number of participants and with longer duration have detected a beneficial effect (20,217). 
Only a few studies have reported the effect of resistance training on cognitive function. These 
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studies have been promising while showing beneficial effect of strength training on cognition 
(218-220).  
In conclusion, the results from epidemiological studies have detected a beneficial effect of 
physical activity and cardiorespiratory fitness whereas inconsistent results have emerged from 
randomized controlled trials (214). Several reasons may explain these contradictions (214). The 
length of intervention studies has been usually relatively short, ranging from 12 weeks to 2 years. 
In observational studies, in general, the follow-up has been longer, ranging from 2 to 28 years. 
Since the development of cognitive impairment may take years or decades, it is possible that the 
detection of the effect of physical activity on cognition requires a long follow-up time. 
Furthermore, most of the randomized controlled trials have not controlled the physical activity 
or cardiorespiratory fitness level at baseline. For example, participants may have been already 
active at baseline and thus the effects on cognition may not be observed during the intervention. 
In contrast, in epidemiological studies levels of physical activity have varied extensively, thus, 
the effect of different physical activity levels are easier to capture. On the other hand, adherence 
to the intervention goals has been relatively poorly reported and may have been at a low level, at 
least in some studies. In addition, randomized controlled trials have been very heterogenic 
regarding the study designs, inclusion criteria, exercise programmes and cognitive measures. 
Randomized controlled trials with longer intervention durations and controlled baseline 
characteristics of the participants (i.e. level of physical activity, gender, age, cognitive status) are 
needed. 
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2.2.5 Other factors and cognitive function 
 
Ageing is the most dominant risk factor for the dementia since after the age of 65, the prevalence 
is doubling with every 5-year increment in age (11). However, individuals of working age are 
affected as well since from 2 to 10% of all dementia cases start before the age of 65. Another non-
modifiable risk factors for dementia are genes (228). In particular, the apolipoprotein E ɛ4 allele 
is associated with an increased risk of Alzheimerʼs disease and vascular dementia. 
The metabolic syndrome has been associated with worse cognitive function (229) and higher 
risk of suffering Alzheimerʼs disease (230,231) in cross-sectional studies and with a higher risk of 
cognitive decline (9,232-235) and vascular dementia (236) in prospective observational studies. 
However, not all studies have found such associations (237-239), and even a protective role of the 
metabolic syndrome has been detected among the oldest old (237,239). These studies have been 
conducted mostly among individuals over 65 years of age and only one has reported associations 
of midlife metabolic syndrome with cognitive function later in life (9).  
In fact, the role of vascular factors may be different at midlife and at older age. Data from 
prospective studies indicate that hypertension (240-244), hypercholesterolemia (241-243), and 
overweight and obesity (245,246) at midlife are associated with increased risk of developing 
dementia at older age. In contrast to these findings, a decrease in total cholesterol (247), blood 
pressure (248) and body mass index (249,250) later in life has been associated with an increased 
risk of dementia. It is not clear whether these declines are true risk factors for dementia or markers 
of incipient dementia. Other potential explanations for the inconsistent findings include survival 
bias in studies involving the oldest old and differences in the ability of cognitive tests to detect a 
decline. Contrary to other vascular risk factors, type 2 diabetes at midlife (243,251) and later in 
life (10,252-254) have both been associated with a higher risk of dementia. 
Based on data from prospective studies some social and psychological factors play a role in 
cognitive function and dementia. A higher level of education has been associated with better 
cognitive performance (255) and with a lower risk of mild cognitive impairment and Alzheimerʼs 
disease (256) but not with a change in cognitive function (255). Cognitively active individuals, 
e.g. those who read books and newspapers, solve crossword puzzles and participate in courses, 
have a lower risk of mild cognitive impairment and dementia including Alzheimerʼs disease and 
vascular dementia (256,257). In addition, a wide social network can protect against dementia 
(258), and it may even reduce the deleterious effect of Alzheimerʼs disease pathology on cognitive 
function by developing a cognitive reserve (259). The presence of depressive symptoms and 
depression in midlife or later in life both have been associated with an increased risk of dementia 
(260,261). Smoking increases the risk of developing dementia (262,263) and cognitive decline 
(264,265).  
 
2.3 SUMMARY OF THE REVIEW OF THE LITERATURE 
In conclusion, a healthy diet, physical activity and cardiorespiratory fitness have been associated 
with a lower risk of the metabolic syndrome and cognitive impairment. Specifically, a diet with 
daily consumption of fruit and vegetables, whole grain products and low-fat dairy products, 
weekly consumption of fish, nuts and legumes, and only occasional consumption of red meat, 
high-fat dairy products and food items rich in sugar and saturated fatty acids is associated with 
better vascular health and cognition. This type of diet can be designated by a variety of names 
such as the Mediterranean diet, the DASH diet or the Nordic diet. These dietary patterns share 
several main features but differ in details (e.g. recommended oil and vegetables). In addition, 
regular physical activity and higher levels of cardiorespiratory fitness have been associated with 
a lower risk of the metabolic syndrome and cognitive impairment.  
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Data regarding the vascular and brain health effects of these lifestyle factors are available 
mainly from cross-sectional and prospective observational studies, and only in a few cases from 
randomized controlled trials. These kinds of study designs have advantages and disadvantages. 
The randomized controlled trial is often claimed to be the gold standard. However, in lifestyle 
studies, especially in dietary trials, it is difficult, or even impossible, to change one component 
without affecting some others. For example decreased consumption of fat will lead to weight 
reduction and/or increased intake of carbohydrates or protein. In such a situation, the observed 
effect cannot be explained only by decreased consumption of fat, the effect may just as well be 
attributable to these other changes. In addition, even randomized controlled trials may vary 
significantly and it has been claimed that reporting in many cases has been inadequate (266). 
As mentioned, there has been extensive heterogeneity regarding the study designs, studied 
populations, sample sizes, duration of studies, adjustments for confounding factors and 
recommendations included in the lifestyle changes in the intervention and control groups. In 
addition, the methods to define the metabolic syndrome or cognitive impairment have varied in 
studies as have assessment methods of diet, physical activity and cardiorespiratory fitness. These 
differences make it almost impossible to draw generalizations from the observed effects and 
associations. Thus, well designed and reported studies with larger sample sizes and appropriate 
assessment methods are needed.  
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3 Aims of the study 
The aim of the present thesis was to study the independent and combined associations of diet 
and cardiorespiratory fitness with the metabolic syndrome and cognitive function in middle-aged 
and elderly men and women.  
 
The specific aims were to study: 
 
1. The associations of intakes of selected food items and nutrients with the risk of having 
metabolic syndrome. 
2. The independent and combined associations of diet score and cardiorespiratory fitness with 
the risk of having metabolic syndrome. 
3. The association of the Nordic diet with cognition during a four-year follow-up. 
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4 Methods 
4.1 STUDY POPULATION 
The subjects in all of the original studies in this thesis were participants of the Dose-Responses to 
Exercise Training (DR’s EXTRA) Study which was a four-year population-based randomized 
controlled trial on the health effects of regular physical exercise and diet (ISRCTN45977199, 
http://isrctn.org). A flow chart of the DR’s EXTRA Study is presented in Figure 3. A random 
population sample of 1500 men and 1500 women, 55-74 years of age, living in the city of Kuopio 
in Eastern Finland was taken from the Finnish Population Register. After a two-year run-in 
period, 1479 men and women participated in the baseline examinations in 2005-2006. Exclusion 
criteria were conditions that would prevent safe engagement in exercise training, serious medical 
conditions (e.g. severe cardiovascular disease, neurological disease and oncological diseases), 
and other conditions preventing co-operation (e.g. dementia, excess alcohol intake), as judged by 
the research physicians. Altogether 1410 men and women who had no exclusion criteria were 
randomized into one of the 5 intervention groups (aerobic exercise, resistance exercise, diet, 
combined aerobic exercise+diet or combined resistance exercise+diet) or the reference group. 
Altogether, 1292 individuals participated in the two-year examinations, thus the drop-out rate 
was 8% in the mid-point of the study. Ultimately, a total of 1199 individuals completed the study 
and participated in the final four-year examinations. Thus, the drop-out rate at the end of the 
study was 15% (15% in the reference group, 14% in the aerobic exercise group, 15% in the 
resistance execise group, 17% in the diet group, 12% in the combined aerobic exercise+diet group 
and 18% in the combined resistance execise+diet group). The mean duration of the intervention 
period was 4.4 years.  
The study protocol was approved by the Research Ethics Committee of the Northern Savo 
Hospital District. Written informed consent was obtained from all study participants.  
Basic characterisics of the study participants are presented at Table 7. Food consumption, 
nutrient intake and levels of cardiorespiratory fitness and physical activity at baseline are 
presented in Table 8. Altogether 54% reported ≥150 minutes of moderate-to-heavy aerobic 
exercise, <1% reported resistance exercise, 42% reported consumption of vegetables ≥400 g/day 
and 55% of fish ≥2 servings/week, and 44% intake of fiber ≥14 g/1000 kcal and 34% intake of SFA 
≤10 E%. A total of 16% did not achieve any of these dietary goals whereas 7% reached all four 
dietary goals (Figure 4). 
Those individuals who were excluded at the baseline measurements (n=69) were older, less 
educated, had more depressive symptoms, lower CERAD-TS and MMSE score, higher waist 
circumferences, BMI values, plasma glucose concentrations and serum triglyceride 
concentrations, lower serum HDL cholesterol concentrations, worse smoking status, more type 2 
diabetes, coronary heart disease and stroke, lower VO2max and less moderate-to-heavy aerobic 
exercise, and used less vegetables, fruit and berries than the participants (n=1410). Those who 
dropped out between randomization and the four-year examinations (n=211) were older, had 
lower CERAD-TS, higher BMI values and had consumed less vegetables, fruit and berries and 
fish, had lower VO2max but were equally active in terms of moderate-to-heavy aerobic exercise at 
baseline compared to those who completed the trial (n=1199).  
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16 010 
Original subject source of men and women aged 55-74 
years  
n=3000 
Random sample invited to the study in 2002 
 
Figure 3. Flowchart of the DRʼs EXTRA Study 
1199 participated in 4-year examinations in 2009 – 2011 (drop-out rate 15%) 
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Table 7. Basic characteristics of the DRʼs EXTRA participants at baseline.  
 
 All 
(n=1410) 
Men 
(n=696) 
Women 
(n=714) 
P for 
difference 
between 
genders 
Age (years) 66.4 (5.4) 66.3 (5.4) 66.6 (5.3) 0.259 
Education (years) 11.2 (3.9) 11.1 (3.9) 11.3 (3.8) 0.320 
Weight (kg) 77.1 (14.9) 83.6 (13.7) 70.7 (13.1) <0.001 
Height (cm) 166.7 (9.1) 173.6 (6.1) 159.9 (5.9) <0.001 
Body mass index (kg/m2) 27.7 (4.5) 27.7 (4.0) 27.7 (5.0) 0.871 
Waist circumference (cm) 93.9 (13.1) 99.0 (11.2) 88.9 (13.0) <0.001 
Serum total cholesterol (mmol/l) 5.1 (0.9) 4.9 (0.9) 5.2 (0.9) <0.001 
Serum LDL cholesterol (mmol/l) 3.2 (0.8) 3.2 (0.8) 3.2 (0.8) 0.238 
Serum HDL cholesteroll (mmol/l) 1.7 (0.5) 1.5 (0.4) 1.9 (0.5) <0.001 
Serum triglycerides (mmol/l) 1.3 (0.7) 1.4 (0.8) 1.3 (0.6) 0.024 
Plasma glucose (mmol/l) 5.8 (1.0) 6.0 (1.1) 5.7 (0.8) <0.001 
Systolic blood pressure (mmHg) 148 (20) 145 (19) 150 (21) <0.001 
Diastolic blood pressure (mmHg) 83 (9) 84 (9) 82 (9) <0.001 
Metabolic risk factors (number)a 1.9 (1.1) 1.9 (1.1) 1.9 (1.1) 0.329 
Metabolic syndrome (%)a 26 28 25 0.311 
Diabetes (%)b 13 16 11 0.011 
Prevalent cardiovascular disease (%)c 22 26 18 <0.001 
Lipid lowering medication (%) 35 35 35 0.767 
Antihypertensive medication (%) 42 41 43 0.649 
Antidiabetic medication (%) 7 9 5 0.001 
Smoking, never/ past/ current (%) 54/35/11 35/51/14 74/19/7 <0.001 
CERAD total score (points) 82.5 (9.2) 81.6 (9.4) 83.4 (9.0) <0.001 
Mild cognitive impairment (%)d 11 11 10 0.495 
MMSE (points)e 28.0 (3.0) 28.0 (2.0) 28.0 (3.0) 0.357 
Symptoms of depression (points)e, f 8.0 (8.0) 6.0 (9.0) 8.0 (9.0) <0.001 
Values are means (SD), emedian (IQR) or percentages. P-values are from independent samples t-test, 
Mann-Whitneyʼs U test or 2-test. aDefined by the the National Cholesterol Education Program criteria 
(54). bIncluding self-reported prediabetes, type 1 diabetes and type 2 diabetes. cIncluding coronary 
heart disease, stroke, transient ischaemic attack (TIA) and claudication. dCERAD total score ≤70 
points. fAssessed by the Center for Epidemiological Studies Depression Scale (267). Abbreviations: 
CERAD = the Consortium to Establish a Registry for Alzheimer’s Disease neuropsychological battery 
(268); MMSE = the Mini-Mental State Examination (153). 
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Table 8. Food consumption, nutrient intake, cardiorespiratory fitness and physical activity of the DRʼs 
EXTRA participants at baseline. 
 
 All 
(n=1394a) 
Men 
(n=686) 
Women 
(n=708) 
P for 
difference 
between 
genders 
Energy intake (kcal) 1673 (456) 1887 (471) 1466 (327) <0.001 
Energy intake (MJ) 7.0 (1.9) 7.9 (2.0) 6.1 (1.4) <0.001 
Carbohydrates (E%) 46.9 (7.2) 45.5 (7.8) 48.2 (6.2) <0.001 
Fat (E%) 30.8 (5.9) 31.2 (6.1) 30.4 (5.6) 0.005 
SFA (E%) 11.5 (3.0) 11.6 (3.1) 11.4 (3.0) 0.126 
MUFA (E%) 10.3 (2.5) 10.6 (2.6) 10.1 (2.4) <0.001 
PUFA (E%) 5.5 (1.5) 5.6 (1.5) 5.4 (1.6) 0.012 
Protein (E%) 18.1 (2.9) 17.8 (2.9) 18.4 (2.8) <0.001 
Alcohol (E%) 2.6 (5.0) 3.9 (6.3) 1.4 (2.9) <0.001 
Dietary fiber (g/1000 kcal) 13.8 (4.0) 13.1 (4.1) 14.5 (3.8) <0.001 
Vegetables (g/day)b 169 (99) 155 (96) 183 (100) <0.001 
Fruit and berries (g/day)c 203 (186) 188 (204) 213 (172) <0.001 
Fish (g/day)c 36 (58.2) 39.8 (72.9) 32.4 (49.1) 0.012 
Meat (g/day)d 118 (70) 142 (78) 94 (51) <0.001 
VO2max (ml/kg/min)e 23.7 (6.3) 26.5 (6.3) 21.0 (4.9) <0.001 
Moderate-to-heavy aerobic exercise 
(min/week)c, f 
143 (226) 136 (225) 149 (224) 0.774 
Resistance exercise (times/week)c, f 0.0 (0.0) 0.0 (0.6) 0.0 (0.0) 0.028 
Values are means (SD) or c median (IQR). P-values are from independent samples t-test or Mann-
Whitneyʼs U test. aComplete data of dietary intake were available for 1394 individuals. bIncluding 
roots, non-root vegetables, legumes, nuts and mushrooms. dIncluding beef, pork, poultry, game, 
sausage and giblets. eAccurate data of VO2max were available for 1349 individuals. fComplete data of 
physical activity were available for 1407 individuals (694 men, 713 women). Abbreviations: SFA = 
saturated fatty acids; MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; 
VO2max = maximal oxygen uptake. 
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Figure 4. Distribution of the number of achieved dietary goals among study participants at baseline 
(n=1394). Dietary goals were: vegetables ≥400g/day, fish ≥2 servings/week (=30g/day), dietary 
fiber ≥14g/1000kcal, and SFA <10E%.  
4.2 STUDY DESIGN 
Designs of the original studies are summarised in Table 9. Studies I and II were based on the 
baseline examinations, and associations were estimated between the different dietary factors and 
cardiorespiratory fitness with the metabolic syndrome. Of those 1410 men and women who were 
randomized into the study, the vast majority (1334; 663 men, 671 women) were included in the 
analyses after excluding those with missing or insufficient data on diet (n=13), cardiorespiratory 
fitness (n=58) or both (n=3) or symptoms of depression or cognition (n=2). Study III was based on 
baseline and four-year examinations. As the aim of that study was to examine whether the Nordic 
diet, i.e. a specific dietary pattern, would be associated with cognitive function after four-years, 
the study groups were pooled in the analyses and thus the study design was a follow-up. Of those 
1199 individuals who participated in the four-year examinations, complete data were available 
for 1140 individuals (567 men, 573 women) after excluding those with missing or insufficient data 
on baseline diet (n=8), cardiorespiratory fitness (n=46) or both (n=2), or cognitive tests at four-year 
examinations (n=3).  
 
Table 9. Summary of the designs, materials and outcomes of interest in the original studies. 
 
Study Design Subjects Exposure  Outcome  
I Cross-sectional n=1334 
(663 men, 671 women) 
 
Food items and 
nutrients 
Metabolic syndrome 
assessed by NCEP criteria 
II Cross-sectional n=1334 
(663 men, 671 women) 
 
Healthy diet scorea and 
cardiorespiratory fitness 
Metabolic syndrome 
assessed by NCEP criteria 
III 4-year follow-up n=1140 
(567 men, 573 women) 
The Nordic diet scoreb Cognitive function 
assessed by CERAD-TS, 
its subtests and MMSE 
a and b Both diet scores are described in chapter 4.3. Abbreviations: NCEP = the National Cholesterol 
Education Program criteria (54); CERAD-TS = total score to describe global cognition assessed by the 
Consortium to Establish a Registry for Alzheimer’s Disease neuropsychological battery (268,269); 
MMSE = The Mini-Mental State Examination (153). 
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4.2.1 Examination protocol 
Individuals were invited to the examination visits by a letter which contained general information 
about the study, instructions to prepare for laboratory measurements and the self-administered 
questionnaire of background information with instructions on how to fill in the form. Those who 
did not respond to the invitation letter were phoned to determine the reason for non-
participation.  
A wide variaty of examinations were performed at baseline and at the two- and four-year 
visits. In the present thesis, the data shown in figure 5 from the baseline and four-year 
examinations were used. The examinations were carried out over three days, approximately 
seven days apart. In the baseline examinations, at the first visit, participants provided written 
informed consent and blood samples for laboratory determinations. Before these measurements, 
the participants were instructed to fast for 12 hours and to abstain from drinking alcohol for three 
days, from smoking for 12 hours and from intense physical activity for one day. During the same 
visit, the participants returned the questionnaire of background information (including questions 
about diseases, medications and smoking), and anthropometric measurements were conducted. 
In addition, a four-day food record and a physical activity questionnaire was given to the 
participants with verbal and written instructions. At the second visit, a cognitive test battery 
including a depression scale was performed, and the questionnaires distributed at the first visit 
were returned and missing information was completed. In addition, the questionnaire about 
background information was checked and completed and blood pressure was measured. At the 
third visit, a maximal cycle ergometer exercise test and the randomization into either the 
reference group or to one of the five intervention groups was performed. The same protocol was 
followed at four-year examinations. 
 
 
 
1 week 1 week INVITATION 
LETTER 
VISIT 2 VISIT 1 VISIT 3 
Included: 
- General information 
about the study 
- Instruction to prepare 
for laboratory 
measurements 
- Questionnaire of 
background 
information 
Included: 
- Informed consent 
- Collection of blood 
samples 
- Measurement of 
anthropometry 
- Return of 
questionnaire of 
background 
information 
- Assignment of a 4-day 
food record and 
physical activity 
questionnaire 
Included: 
- Assessment of 
cognitive function, 
depressive symptoms 
and blood pressure 
- Return of a 4-day 
food record and 
physical activity 
questionnaire 
- Completion of missing 
information in any 
questionnaire 
Included: 
- Maximal cycle 
ergometer exercise 
test 
- Randomization 
Figure 5. Assessments at each study visit at baseline and at four-year examinations utilized in the present 
thesis. 
2 weeks 
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4.2.2 Intervention protocol for reference and intervention groups  
At baseline, individuals in the reference group were reminded of the general recommendations 
on healthy diet in accordance with the Finnish Nutrition Recommendations and regular physical 
activity for a minimum of 30 minutes of moderate exercise on most days of the week. 
Participants in the aerobic exercise group were prescribed an individualised progressive 
training program (Table 10) by an exercise physiologist. Personal factors such as 
cardiorespiratory fitness, preferred forms of aerobic exercise, overall health and possibilities to 
carry out the program were taken into account. The main exercise modes were walking, skiing, 
jogging, running, Nordic walking, biking and swimming. Training frequency, duration and 
intensity were gradually increased during the first six months. Thereafter, the participants were 
further randomized into a lower (5x60 minutes/week) or a higher (5x90 minutes/week) volume 
training group in which the training intensity corresponded to 55-65% of VO2max. The participants 
performed training by themselves and were instructed to monitor training intensity via a heart 
rate monitor or by palpating arterial pulse.  
Individuals in the resistance exercise group participated in an individually prescribed 
progressive strength training program (Table 11) supervised and controlled by an exercise 
physiologist. After a one month familiarising period, the training frequency and intensity were 
gradually increased during the first six months. Thereafter, the participants were randomized 
into a lower (2 sessions/week) or a higher (3 sessions/week) volume training group. In addition, 
the participants were advised to carry-out aerobic exercise training throughout the study. 
Training load was quantified based on 1 repetition maximum (RM) assessed by 3-5 RM or 16-20 
RM tests. The training loads were adjusted on demand throughout the four-year intervention 
period and RM tests were carried out at 1, 3, 6, 24, 36 and 48 months. A personal smart card 
contained the training program and stored the exercise data. Resistance training took place in the 
fitness facility of the Kuopio Research Institute of Exercise Medicine and air resistance equipment 
(HUR Ltd, Finland) was used.  
Individuals in the diet group received counselling by authorised nutritionists. Dietary advices 
were tailored individually based on their usual diet and current health status. All instructions 
were given at a food level (e.g. instead of an abstract goal of decreasing intake of saturated fat, 
the advice at the food level was to substitute high-fat dairy products with low-fat dairy products). 
Spouses, if they were in charge of preparing meals at home, were asked to be present at the advice 
sessions. During the first six months, each advice session had a pre-defined topic (e.g. importance 
and sources of saturated and unsaturated fatty acids and fiber in the first session). Printed 
material was used to back up the advice and to serve as a reminder at home. In the individualised 
counselling, personal factors such as current diet, favorite dish, food allergy and possibilities to 
carry out the program (e.g. finances and cuisine) were taken into account. During the first six 
months, all participants were given instructions based on the Finnish Nutrition 
Recommendations (FNR) (270). The goals are presented in detail in Table 12, briefly the 
participants were requested to consume 1) ≥400 g/day of vegetables including fruit and berries, 
2) ≥2 servings of fish/week (≥30 g/day), 3) ≥14 g of dietary fiber/1000 kcal, and 4) ≤10% of daily 
energy intake from saturated fatty acids. After six months, the subjects were further randomized 
into two subgroups: FNR and Special Nutrition (SN) group. The FNR group continued with the 
usual recommendations and the SN group was instructed, in addition to the recommendation to 
adhere to FNR, to have a higher consumption of vegetables, fruit and berries (≥ 600 g/day) and 
add nuts and almonds ≥30 g/day. 
The combined aerobic exercise+diet group was prescribed aerobic exercise 5x60 minutes/week 
and FNR. The combined resistance exercise+diet group was prescribed resistance exercise two 
sessions/week and FNR.  
Participants in the aerobic exercise, resistance exercise and diet groups had 11 and in the 
combined aerobic exercise+diet and resistance exercise+diet groups 22 individual face-to-face 
advice sessions lasting 30 (follow-up sessions) to 60 minutes (the first session) with an authorized 
nutritionist or exercise physiologist during the intervention. The first 6 months included 4 
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sessions (at baseline and after 1, 3 and 6 months) and thereafter every 6 months during the 
intervention. In addition, group sessions (15 to 20 participants per session) were arranged at 3 
months and 24 months after the first advice session to further improve motivation and adoption 
of interventions. In the first group sessions, the main goals were to offer practical advice e.g. how 
to read and understand package markings to identify the proper food products in the market in 
the diet groups, advice about the correct Nordic walking technique in aerobic exercise groups, 
and explaining the importance of muscle strength on functional capacity in resistance exercise 
groups. In the second group session, the main goal was to morale-boosting and maintaining 
motivation (e.g. participants were asked to evaluate their success in the lifestyle changes during 
the intervention). Spouses could also attend all of the counselling sessions. The overall goal of 
face-to-face and group sessions was to provide the knowledge, skills and motivation to achieve 
gradual, permanent lifestyle changes in diet and/or physical exercise.  
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Table 10. Progression of the aerobic exercise training program in the aerobic exercise and 
diet+aerobic exercise groups. 
 
 0-1 months 1-3 
months 
3-6 months 6-48 months 
Energy expenditure (kcal/week) <500 500 - 600 700 - 900 1000 - 
1500 
>1500a 
Exercise frequency (times/week) 2 3 4 5 5 
Duration of exercise (min) 30-45 45-60 60 60 90 
Intensity (% of VO2max) 40 50 60 55-65 55-65 
Exercise mode Dynamic aerobic exercise occupying large muscle groups 
aOnly in aerobic exercise group. Abbreviations: VO2max = maximal oxygen uptake. 
 
 
Table 11. Progression of the resistance exercise training program in the resistance exercise and 
diet+resistance exercise groups. 
 
 0-1 
month
s 
1-3 
months 
3-4 
months 
4-6 
months 
6-48  
months 
Energy expenditure (kcal/week)  <500 500 - 600 800-1300 1000-1500 1000-1500 >1500a 
Exercise frequency 
(times/week) 
1 2 2 2 2 3 
Number of muscle groups  10-14 10-14 10-14 10-14 10-14 10-14 
Repetitions/ set 10 10 15 15 15 15 
Load (% of 1RM) light 40-50 60 60 60 60 
Number of sets 1 1 1 2 2 2 
Aerobic exercise (min/week) 30 60 60 90 150 180 
aOnly in resistance exercise group. Abbreviations: RM = repetition maximum.  
 
Table 12. Main dietary goals in the diet (FNR or SN), diet+aerobic exercise (FNR) and 
diet+resistance exercise (FNR) groups. 
 
 FNR SN Goals at nutrient level 
Vegetables 400 g/day 600 g/day Fiber and antioxidants ↑ 
Fruit and berries 2-3 servings/day* 4 servings/daya Fiber and antioxidants ↑ 
Dairy products Fat-free and low-fat, 4 servings/dayb Enough calsium; 
saturated fat ↓ 
Fish  2-3 times/wk Unsaturated fat ↑ 
Red meet Select low-fat Select low-fat; decrease use Saturated fat ↓ 
Poultry No specific instructions Increase use Saturated fat ↓ 
Soft margarines, oil Increase use e.g. in cooking and on bread Unsaturated fat ↑ 
Grain products Mainly whole grain products, 6-10 servings/day Fiber and antioxidants ↑ 
Nuts and almonds No special instructions ½ dl/day (≥30 g/day) Unsaturated fat ↑ 
Salt Decrease use in cooking and select low-salt products Sodium ↓ 
a1 serving = 1 fruit or 2 dl berries. Fruit and berries are included in total amount of vegetables. 
b1 serving = 2 dl liquid dairy products (e.g. milk, sour milk, yoghurt) or 2 slices cheese. 
Abbreviations: FNR = Finnish Nutrition Recommendations (271); SN = Special Nutrition; ↑ = increase; 
↓ = decrease. 
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4.3 ASSESSMENT OF DIET 
Dietary intake was assessed by a four-day food record including three weekdays and one 
weekend day. Food records were given to the participants on the first study visit and were 
returned one week later. Recording dates were defined by the researcher according to the days 
of study visits and were 1) from Wednesday to Saturday, 2) from Thursday to Monday, except 
Sunday, or 3) from Sunday to Wednesday. The participants were given detailed written and 
verbal instructions and they were encouraged to report the amount and quality of eaten foods 
and drinks as precisely as possible (e.g. fat content, amount of fiber, cooking method). When it 
was returned, the food record was checked and completed, if necessary, by a clinical nutritionist 
or a trained nurse. The amount of food consumed was estimated by a picture booklet of portion 
sizes (272), using household gauges or weighing. Data from food records were analyzed using 
the MicroNutrica nutrient calculation software, version 2.5 (recipes updated in 2007) (Finnish 
Social Insurance Institution, version 2.5, Turku, Finland) (273).  
In Study I, food items and nutrients were selected based on the nutrition recommendations of 
the American Diabetes Association (274) and were completed with food items relevant in the 
Finnish diet. The following food items were selected: total consumption of vegetables (g/day) 
(including roots, non-root vegetables, mushrooms, legumes and nuts), non-root vegetables 
(g/day), legumes and nuts (g/day), berries (g/day), white bread (g/day), fish (g/day), sausage 
(g/day) and sugar (g/day). Further, selected nutrients were: energy intake (MJ), carbohydrates 
(E%), fat (E%), SFA (E%), MUFA (E%), PUFA (E%), protein (E%), dietary fiber (g/1000 kcal), 
cholesterol (mg/day), sodium (g/day), potassium (g/day), vitamin C (mg/day), vitamin E 
(mg/day), vitamin D (μg/day), carotenoids (mg/day), chromium (μg/day), magnesium (mg/day) 
and zinc (mg/day). 
In Study II, a 5-grade diet score was created according to the number of achieved dietary goals 
of nutrition recommendations (scale 0-4) (274). The four goals were ≥400g of vegetables per day, 
≥2 servings of fish per week (=30g of fish per day), ≥14g of fiber per 1000kcal, and <10E% of daily 
intake of saturated fatty acids (SFA). Vegetables included roots, non-root vegetables, mushrooms, 
legumes and nuts, fruit and berries, but not potatoes. Fish included fatty and lean fish and 
processed fish products.  
In Study III, the Nordic diet score was created, modified from the Baltic Sea diet score devised 
by Kanerva et al. (275). The Nordic diet score consists of eight variables: consumption of fish 
(g/day; including fatty and lean fish and processed fish products), vegetables (g/day; including 
roots, non-root vegetables, mushrooms, legumes and nuts, but not potatoes), fruit and berries 
(g/day), whole grain bread (g/day), meat (g/day; including beef, pork, poultry, game, sausage and 
giblets) and alcohol (g/day), and intake of α-linolenic acid (g/day; to represent the consumption 
of rapeseed oil) and unsaturated fatty acids-to-total fat ratio. The Nordic diet score was calculated 
according to the gender-specific quartiles of consumption or intake of each component, with the 
exception of the consumption of alcohol. For the recommended food items and nutrients (fish, 
vegetables, fruit and berries, whole grain bread, α-linolenic acid and the ratio of unsaturated fatty 
acids-to-total fat), the lowest quartile was coded as 0, the two middle quartiles as 1 and 2 and the 
highest as 3. For meat, the highest quartile was coded as 0, the two middle quartiles as 1 and 2 
and the lowest as 3. Consumption of alcohol was dichotomized based on specific cut-points in 
accordance with the Dietary Guidelines for Americans (276). Non-drinkers (<1 g of alcohol per 
day) as well as heavy drinkers [>24 g (>2 units) of alcohol per day in men and >12 g (>1 unit) in 
women] received 0 points. Mild to moderate drinkers (1-24 g of alcohol per day in men and 1-12 
g in women) received 1 point. Hence, the Nordic diet score ranged from 0 to 22 points with higher 
points indicating better adherence. 
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4.4 ASSESSMENT OF PHYSICAL ACTIVITY AND CARDIORESPIRATORY 
FITNESS  
Cardiorespiratory fitness was assessed as maximal oxygen uptake (VO2max, ml/kg/min) measured 
directly by the breath-by-breath method using a paramagnetic oxygen analyzer (VMax 29, 
SensorMedics Corporation, Yorba Linda, California, USA) during a maximal symptom-limited 
exercise stress test on an electrically-braked cycle ergometer (Ergoline, Biz, Germany). To 
standardize the conditions before the test, the subjects received written instructions to take their 
medications normally, and to avoid strenuous exercise for at least 24 hours, heavy meals, coffee, 
tea and cola drinks for at least two hours, alcohol drinking for at least 48 hours and cigarette 
smoking for at least four hours before the exercise test. A nurse confirmed these prerequisites and 
a physician interviewed and examined the subjects to evaluate any contraindications. In addition, 
tests were supervised by a physician and a nurse. The standardized testing protocol included a 
three-minute warm-up at a workload of 20 W followed by 20 W increments per minute until 
exhaustion. Electrocardiography was recorded throughout the exercise test (GE Medical System, 
Freiburg, Germany). VO2max was defined as the mean of the three highest values of the average 
oxygen consumption measured consecutively over 20 second intervals. The exercise test was 
considered maximal if the respiratory exchange ratio was ≥1.1 or if the test had to be terminated 
due to cardiovascular or pulmonary reasons, muscle fatigue, or overall fatigue. Participants were 
verbally encouraged to reach their maximum. In Study II, VO2max was categorised into age and 
gender specific tertiles (Table 13), and in other studies used as continuous variable. 
Physical activity was assessed by a Minnesota Leisure Time Physical Activity Questionnaire 
(277) using the Finnish version which was modified by Lakka et al. (278). The participants recalled 
the frequency, mean duration and mean intensity of 24 different leisure-time physical activities, 
including walking and cycling for commuting, walking, jogging, cross-country skiing, resistance 
training, berry picking and gardening, during the previous 12 months. Occupational physical 
activities were not included in the questionnaire. To improve the accuracy of the 12 months’ 
questionnaire, the participants were given face-to-face detailed instructions to fill in the form, 
which was further checked at return. The intensity of each physical activity was based on age and 
gender specific metabolic equivalents (MET) (1 MET is defined as the energy expenditure at rest, 
corresponding to a 3.5 ml O2/kg) values given for each physical activity. The level of physical 
activity was described as the duration (minutes/week) of moderate-to-heavy aerobic exercise 
(including leisure-time and commute physical activities) and frequency (times/week) of 
resistance exercise. 
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Table 13. Cut-points of VO2max tertiles in age and gender specific groups. 
 
Age VO2max Men Women 
 tertile VO2max  n VO2max  n 
<60 Low <26.5 34 <21.0 30 
 Middle 26.5 - 31.3 34 21.0 - 25.4 30 
 High >31.3 34 >25.4 30 
 
60 – 64.9 Low <25.4 64 <19.2 64 
 Middle 25.4 - 30.5 65 19.2 - 24.4 65 
 High >30.5 66 >24.4 64 
 
65 – 69.9 Low <23.2 65 <18.3 70 
 Middle 23.2 – 29.1 66 18.3 – 21.8 68 
 High >29.1 65 >21.8 68 
 
70 – 74.9 Low <20.8 39 <17.4 44 
 Middle 20.8 – 25.6 42 17.4 – 20.8 45 
 High >25.6 41 >20.8 43 
 
≥75 Low <19.1 16 <16.5 16 
 Middle 19.1 – 23.9 16 16.5 – 19.8 17 
 High >23.9 16 >19.8 17 
Abbreviations: VO2max = maximal oxygen uptake (ml/kg/min). 
 
4.5 DEFINITION OF METABOLIC SYNDROME 
Metabolic syndrome was defined by the National Cholesterol Education Program (NCEP) criteria 
(54). A participant was classified as having metabolic syndrome if he/she had ≥3 of the following 
criteria: waist circumference >102 cm in men and >88 cm in women; serum triglycerides ≥1.7 
mmol/l; serum HDL cholesterol <1.03 mmol/l in men and <1.29 mmol/l in women; systolic blood 
pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or use of antihypertensive 
medication; fasting plasma glucose ≥6.1 mmol/l.  
Waist circumference was measured in a standing position on bare skin at the end of normal 
exhalation, at the mid-distance between the bottom of the rib cage and the top of the iliac crest 
with the 0.5 cm accuracy. The mean of two measurements was used. Venous blood samples were 
collected without stasis into glass tubes in the morning after 12-hour fasting and samples were 
analyzed daily. Serum HDL cholesterol (HDL-Cholesterol, Thermo Electron Corporation, 
Finland) and serum triglycerides (Triglycerides, Thermo Electron Corporation, Finland) were 
analyzed by enzymatic photometric methods. The hexokinase method (Glucose, Thermo Clinical 
Labsystems Oy, Finland) was used for fasting plasma glucose analyses. Blood pressure was 
measured in the sitting position from the right arm after a five minute rest using a mercury 
sphygmomanometer. The mean of two consecutive measurements was used. Antihypertensive 
medication was asked in a self-administered questionnaire of background information.  
4.6 ASSESSMENT OF COGNITIVE FUNCTION 
Cognitive function was assessed using the standardized Finnish version of Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery (268) at 
baseline and after two and four years. The Mini-Mental State Examination (MMSE) was 
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performed as a part of CERAD battery (153). Trained nurses performed the tests. Individual 
cognitive tests included in the CERAD battery are presented in Table 14. 
The CERAD total score (CERAD-TS) was calculated including Verbal Fluency (scoring range 
0-24), Modified Boston Naming Test (scoring range 0-15), Word List Learning (scoring range 0-
30), Constructional Praxis (scoring range 0-11), Word List Recall (scoring range 0-10) and Word 
List Recognition Discriminability (scoring range 0-10) (269). These subtests assess memory, 
language, learning and constructional praxis. The score ranged from 0 to 100 points with a higher 
score indicating better performance. Points above 70 were classified as normal cognition and 
points 70 or below as impaired cognition (279). 
 
4.7 OTHER ASSESSMENTS 
Body weight was measured by a digital scale with 0.1 kg accuracy and body height by a metal 
scaled height meter with 0.1 cm accuracy wearing light indoor clothing without shoes. Body mass 
index (BMI) was calculated by dividing weight in kilograms by the square of height in meters. 
Symptoms of depression were assessed by the Center for Epidemiologic Studies Depression Scale 
(CES-D) (267). Prevalent use of medications, diseases diagnosed by a physician, smoking status 
(never/past/current) and education (years) were assessed by a self-administered questionnaire. 
Alcohol consumption was assessed by a four-day food record (g/day) in Study III and by a self-
administered questionnaire (doses/week) in other the original studies. Basal metabolic rate (BMR) 
was calculated by the Schofield-equation (280) and was used to assess the extent of dietary 
underreporting.  
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Table 14. Individual cognitive tests included in the CERAD battery. 
 
Test Object to measure Instruction and score 
Verbal Fluency Verbal production, 
semantic memory 
and language 
Participants are asked to name as many animals as possible 
in 1 minute. The score is the total number of different 
animals named. To calculate CERAD total score maximum 
upper limit is set on 24.  
Modified Boston 
Naming Test 
Visual naming Participants are asked to name 15 objects presented as line 
drawings. Three groups of 5 items are displayed, the names 
having high, medium, and low frequency of occurrence in the 
Finnish language. The maximum score is 15. 
Mini-Mental State 
Examination 
Global cognitive 
function 
Includes several short tasks which evaluates different 
cognitive domains (orientation, concentration, memory, 
language and constructional praxis). Maximum score is 30. 
Word List 
Learning 
Ability to remember 
newly learned 
information 
 
Participants read aloud ten printed words three different 
times. Immediately after every reading session, participants 
are asked to recall as many words as possible. The maximum 
score on each trial is 10. The maximum total score is 30. 
Constructional 
Praxis 
Visuo-spatial and 
constructional 
ability. 
 
Four figures with increasing complexity (circle, diamond, 
intersecting rectangles and cube) are presented to the 
participant for copying. The maximum score is 11.  
Word List Recall Delayed memory Five minutes after the Word List Memory task, the 
participants are asked to remember as many words as 
possible. A maximum number of correct responses is 10. A 
saving score is calculated and presented as a percentage 
[(number of delayed words/number of words in trial 3 in the 
Word list memory task)* 100]. 
Word List 
Recognition 
Recognition for the 
10 words of the 
World List Memory 
task 
Participants are asked to recognize 10 words presented in the 
Word List Memory -task among 10 distracting words. 
Correctly recognised words from the list and correctly 
identified distracting words are calculated, scoring 10 points 
of each ending up to total of 20 points. A score is a 
percentage of correctly recognised words from the maximum: 
[(correct Yes-answers + correct No-answers/20) *100]. Word 
List Recognition Discriminability used in CERAD total score 
was calculated by subtracting the number of false Yes-
answers from the number of true Yes-answers. The Maximum 
score is 10. 
Delayed Copying 
of pictures 
Visual memory 
reflecting the 
delayed ability to 
draw the objects 
without model 
Participants are asked to draw four pictures presented in the 
constructional praxis task without a model. A saving score is 
calculated and presented as a percentage [(score at delayed 
drawing/score at copying from object)* 100]. The maximum 
score is 100%. 
Clock drawing Executive function Participants are asked to draw a clock with all numbers, and 
set the hands at ten past eleven. The maximum score is 6. 
Abbreviations: CERAD = the Consortium to Establish a Registry for Alzheimer’s Disease 
neuropsychological battery (268). 
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4.8 STATISTICAL METHODS 
Statistical analyses were performed using the IBM SPSS statistics for Windows, version 19.0 (IBM 
Corp., Armonk, NY). Associations with a P value of <0.05 were considered as statistically 
significant. Differences between groups were analysed by t-test, ANOVA, Mann-Whitney’s U-
test, Wilcoxon Signed-Ranks test, Kruskal-Wallis test, or 2-test as appropriate. The assumption of 
normality was verified using the Kolmogorov-Smirnov test and visual inspection of histograms. 
In Study I, associations between dietary factors and metabolic syndrome were studied by 
logistic regression analysis. Food items and nutrients were used as continuous variables. Food 
items that were associated with the risk of having metabolic syndrome were categorized into 
tertiles, except those including many zero-values which were categorized into non-consumers 
and those below or above median. Four different models were used for data adjustment: 1) age, 
smoking and alcohol consumption; 2) model 1 + education; 3) model 2 + VO2max; 4) model 3 + 
prevalent diseases (type 1 diabetes, type 2 diabetes, pre-diabetes, cancer, and atherosclerotic 
cardiovascular diseases including coronary heart disease, claudication, transient ischaemic attack 
and stroke) and conditions that could have affected food intake (depressive symptoms, cognitive 
function). In additional analyses data were adjusted for variables in model 1 + energy intake. 
In Study II, logistic regression analysis was used to analyse the independent and combined 
associations of the diet score and VO2max tertiles with the risk of having the metabolic syndrome. 
Data were adjusted for: 1) age and gender; 2) model 1 + smoking, alcohol consumption and 
education; 3) model 2 + the diet score or VO2max tertiles; 4) model 3 + prevalent diseases (type 1 
diabetes, type 2 diabetes, pre-diabetes, atherosclerotic cardiovascular diseases and cancer), 
cognitive function, depression, as well as medications for diabetes, hypertension and 
dyslipidemia.  
In Study III, analysis of covariance (ANCOVA) was used to assess the association of the 
baseline Nordic diet with the CERAD-TS and MMSE at four-years among men and women. The 
Nordic diet score was used as a continuous variable. A hierarchical approach was used to show 
the effect of confounding factors to the association between the Nordic diet and cognition. 
Covariates were chosen based on the current knowledge about which factors may be associated 
with cognitive function during ageing. Three models were used for data adjustments: Model 1) 
age, gender, education, baseline CERAD-TS and the study group; Model 2) model 1+smoking, 
symptoms of depression, VO2max and medications (antihypertensive, lipid lowering and 
antidiabetic); Model 3) model 2+energy intake. In the additional analyses (Model 4) data were 
adjusted for the change in the Nordic diet score and VO2max during the four-year study period to 
control for the effects of the intervention.  
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5 Results 
5.1 FOOD CONSUMPTION, NUTRIENT INTAKE AND METABOLIC SYNDROME 
(STUDY I) 
Of the 1334 individuals included in the analyses, a total of 182 men (27%) and 169 women (25%) 
had the metabolic syndrome. Hypertension was the most common single component of the 
metabolic syndrome in both men and women, whereas a low serum HDL concentration was 
present only in 9.6% of all participants (Figure 6). Men and women with the metabolic syndrome 
had worse metabolic risk factor levels and lower VO2max compared to those without it (Table 15). 
In addition, there were more current smokers among men with the metabolic syndrome than in 
men without it. There were several differences in food consumption and nutrient intake in men 
with and without the metabolic syndrome (Table 16). In women with and without the metabolic 
syndrome differences were observed only in the consumption of vegetables, non-root vegetables, 
sausage and whole grain bread (Table 16). 
At four-year examinations of the DR`s EXTRA study, the prevalence of the metabolic 
syndrome was 24% in both genders. The incidence of the metabolic syndrome was 10% in both 
genders at the four-year examinations. 
 
 
 
 
Figure 6. Distribution of the single components of the metabolic syndrome. Metabolic syndrome was 
defined by the National Cholesterol Education Program (NCEP) criteria (54). The following criteria were 
used: waist circumference >102 cm in men and >88 cm in women; serum triglycerides ≥1.7 mmol/l; 
serum HDL cholesterol <1.03 mmol/l in men and <1.29 mmol/l in women; systolic blood pressure 
≥130 mmHg or diastolic blood pressure ≥85 mmHg or use of antihypertensive medication; fasting 
plasma glucose ≥6.1 mmol/l.  
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Table 15. Basic characteristics in men and women with and without the metabolic syndrome. 
 Men Women 
 No MetS 
(n=481) 
MetS 
(n=182) 
P-value No MetS 
(n=502) 
MetS 
(n=169) 
P-value 
Age (years) 66.4 (5.3) 65.9 (5.6) n.s. 66.5 (5.3) 66.3 (5.3) n.s. 
Education (years) 11.3 (3.9) 10.9 (4.0) n.s. 11.3 (3.8) 11.3 (3.7) n.s. 
Weight (kg) 79.8 (10.8) 94.0 (14.6) <0.001 66.6 (10.0) 82.2 (13.6) <0.001 
Height (cm) 174 (6) 174 (6) n.s. 160 (6) 160 (5) n.s. 
Body mass index 
(kg/m2) 
26.5 (3.0) 31.0 (4.2) <0.001 26.0 (3.8) 32.1 (4.9) <0.001 
Waist circumference 
(cm) 
95.3 (8.8) 108.8 (10.4) <0.001 84.2 (10.3) 101.6 (11.1) <0.001 
Serum total cholesterol 
(mmol/l) 
4.9 (0.9) 4.8 (1.0) n.s. 5.3 (0.9) 5.1 (1.0) 0.038 
Serum LDL cholesterol 
(mmol/l) 
3.2 (0.8) 3.2 (0.9) n.s. 3.2 (0.8) 3.3 (0.9) n.s. 
Serum HDL cholesterol 
(mmol/l) 
1.6 (0.4) 1.2 (0.3) <0.001 2.0 (0.5) 1.5 (0.4) <0.001 
Serum triglycerides 
(mmol/l) 
1.1 (0.4) 2.0 (1.0) <0.001 1.1 (0.4) 1.9 (0.8) <0.001 
Plasma glucose (mmol/l) 5.7 (0.6) 6.8 (1.6) <0.001 5.4 (0.5) 6.3 (1.2) <0.001 
Systolic blood pressure 
(mmHg) 
144 (19) 147 (18) n.s. 149 (21) 154 (21) 0.008 
Diastolic blood pressure 
(mmHg) 
84 (9) 85 (10) n.s. 82 (9) 85 (10) <0.001 
Smoking, never/ past/ 
current (%) 
39/49/12 22/57/21 <0.001 74/19/7 73/19/8 n.s. 
CERAD total score 
(points) 
82.0 (9.5) 81.0 (8.7) n.s. 83.9 (8.4) 83.0 (9.6) n.s. 
MMSE (points)a 28.0 (2.0) 28.0 (3.0) n.s. 28.0 (3.0) 28.0 (3.0) n.s. 
Symptoms of depression 
(points)a, b 
6.0 (8.0) 7.0 (9.0) 0.007 8.0 (8.0) 9.0 (8.0) 0.062 
VO2max (ml/kg/min) 27.9 (6.0) 22.7 (5.2) <0.001 21.9 (4.9) 18.1 (3.6) <0.001 
Values are means (SD), amedian (IQR) or percentages. P-values are from independent samples t-test, 
Mann-Whitney’s U-test or 2-test. bAssessed by the Center for Epidemiological Studies Depression Scale 
(267). Abbreviations: MetS = metabolic syndrome; CERAD = the Consortium to Establish a Registry 
for Alzheimer’s Disease neuropsychological battery (268); MMSE = the Mini-Mental State Examination 
(153). 
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Table 16. Consumption of food items and nutrients in men and women with and without the metabolic 
syndrome. 
             Men                 Women 
 No MetS 
(n=481) 
MetS 
(n=182) 
P-value No MetS 
(n=502) 
MetS 
(n=169) 
P-value 
Vegetables (g/day)a 162 (98) 136 (90) <0.001 190 (102) 171 (97) 0.019 
Roots (g/day)b 25.2 (47.1) 19.6 (38.2) 0.068 29.5 (34.0) 26.3 (37.5) n.s. 
Non-root vegetables (g/day) 118 (82) 102 (78) 0.006 147 (87) 132 (85) 0.016 
Legumes and nuts (g/day)b 0.0 (7.7) 0.0 (3.0) 0.001 0.0 (6.2) 0.0 (4.1) n.s. 
Berries (g/day)b 28.8 (57.8) 11.5 (35.3) <0.001 39.0 (65.1) 35.7 (65.5) n.s. 
Fish (g/day)b 42.5 (66.1) 24.8 (68.1) 0.001 33.4 (48.9) 38.4 (52.4) n.s. 
Sausage (g/day)b 18.0 (54.7) 28.0 (74.3) 0.031 5.0 (27.0) 10.0 (36.0) 0.014 
Sugar (g/day) 19.8 (15.3) 13.5 (11.0) <0.001 13.7 (10.7) 12.5 (9.2) n.s. 
White bread (g/day)b 0.8 (5.0) 1.5 (6.1) n.s. 0.8 (3.6) 1.5 (5.0) 0.077 
Whole grain bread (g/day) 127 (69) 116 (75) 0.078 88.3 (42.8) 80.8 (41.5) 0.047 
       
Energy (MJ) 8.1 (1.9) 7.4 (2.0) <0.001 6.2 (1.3) 6.0 (1.4) n.s. 
Carbohydrates (E%) 46.0 (7.8) 44.1 (7.8) 0.005 48.2 (6.3) 48.4 (6.2) n.s. 
Fat (E%) 30.9 (6.0) 32.1 (6.4) 0.024 30.3 (5.6) 30.5 (5.5) n.s. 
SFA (E%) 11.5 (3.0) 12.0 (3.3) 0.045 11.3 (3.0) 11.4 (2.9) n.s. 
MUFA (E%) 10.4 (2.5) 11.1 (2.7) 0.006 10.0 (2.4) 10.1 (2.4) n.s. 
PUFA (E%) 5.6 (1.5) 5.7 (1.4) n.s. 5.4 (1.6) 5.4 (1.5) n.s. 
Protein (E%) 17.6 (2.9) 18.2 (3.0) 0.027 18.4 (2.8) 18.4 (2.9) n.s. 
Dietary fiber (g/1000kcal) 13.3 (4.0) 12.5 (4.3) 0.039 14.6 (3.9) 14.1 (3.5) n.s. 
Values are means (SD) or bmedian (IQR). P-values are from independent samples t-test or Mann-
Whitney’s U-test. aIncludes roots, non-root vegetables, mushrooms, legumes and nuts. Abbreviations: 
E% = percents of total energy intake; MetS = metabolic syndrome; MUFA = monounsaturated fatty 
acids; n.s. = a statistically nonsignificant association; PUFA = polyunsaturated fatty acids; SFA = 
saturated fatty acids.  
 
5.1.1 Food consumption and metabolic syndrome 
In men, the consumption of vegetables, non-root vegetables, berries, legumes and nuts, fish and 
sugar was inversely whereas the consumption of sausage was positively associated with the risk 
of having metabolic syndrome, after adjustment for age, smoking and alcohol consumption. After 
further adjustment for VO2max, the consumption of legumes and nuts, berries and sugar remained 
statistically significantly associated with the metabolic syndrome, whereas the other associations 
disappeared. In women, the consumption of vegetables and non-root vegetables was inversely 
but the consumption of white bread and sausage was positively associated with the risk of having 
metabolic syndrome, after adjustment for age, smoking and alcohol consumption. However, after 
further adjustment for VO2max, these associations were no longer statistically significant. 
Adjustment for education or prevalent diseases and conditions had no effect on the found 
associations either in men or in women. 
The associations between food items as categorized variables and the risk of having the 
metabolic syndrome are presented in Figures 7-10. In men, the consumption of berries had a 
graded and inverse association with the risk of having the metabolic syndrome.  Men in the 
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middle tertile had 31% and in the highest tertile 49% lower risk of having the metabolic syndrome 
compared to those in the lowest tertile after adjustment for age, smoking, alcohol consumption, 
education and VO2max. This association remained after further adjustment for energy intake and 
prevalent diseases and conditions. Sugar consumption displayed an inverse association with the 
metabolic syndrome, but the association disappeared after further adjustments for prevalent 
diseases and conditions. Men in the middle and highest third of the consumption of vegetables, 
non-root-vegetables, legumes and nuts, and fish had almost half the risk of having metabolic 
syndrome than those in the lowest third after adjustment for age, smoking and alcohol 
consumption. In addition, men in the highest third of sausage consumption had a 64% higher risk 
of having the metabolic syndrome than those who did not consume sausages. The association of 
legumes and nuts and fish with the metabolic syndrome remained after further adjustment for 
VO2max, energy intake, education or prevalent diseases and conditions. Other associations 
remained after further adjustment for energy intake but disappeared after adjustment for VO2max. 
Women in the middle and highest tertiles of consumptions of vegetables and non-root 
vegetables had a lower risk of having the metabolic syndrome compared to women in the lowest 
tertile after adjustment for age, smoking and alcohol consumption. In addition, after same 
adjustments consumption of sausage had direct and graded association with the risk of having 
the metabolic syndrome. However, after further adjustments for education and VO2max, only the 
association between consumption of sausage and risk of having the metabolic syndrome 
remained statistically significant (Figures 7-10). 
 
5.1.2 Nutrient intake and metabolic syndrome 
In men, the intake of energy, carbohydrates, dietary fiber, potassium, vitamins C and E, 
carotenoids, chromium, magnesium and zinc was inversely associated with the risk of having 
metabolic syndrome, after adjustment for age, smoking and alcohol consumption. After these 
adjustments, intake of MUFA and protein was directly associated with the risk of having 
metabolic syndrome. In women, intake of magnesium was inversely associated with the risk of 
having metabolic syndrome, whereas other nutrients had no association. After further 
adjustment for VO2max, only energy intake in men was associated with the metabolic syndrome. 
Further adjustment for education or prevalent diseases and conditions did not change any of 
these associations. Associations between nutrient intakes and metabolic syndrome were not 
statistically significant after adjustment for energy intake either in men or women except for the 
intake of vitamin C in men.  
Taken together, in the fully adjusted model, the intakes of nutrients were not associated with 
the risk of having the metabolic syndrome in either men or women. 
 
  
55 
 
 
 
Figure 7. Association of consumption of legumes and nuts with the risk of having the metabolic 
syndrome (MetS) in men and in women. Values are Odds Ratios (OR) with 95% confidence interval 
(CI). Adjusted for age, smoking, alcohol consumption, education and VO2max. P-values are for trend. 
 
Figure 8. Association of consumption of berries with the risk of having the metabolic syndrome 
(MetS) in men and in women. Values are Odds Ratios (OR) with 95% confidence interval (CI). 
Adjusted for age, smoking, alcohol consumption, education and VO2max. P-values are for trend. 
 
Figure 9. Association of consumption of fish with the risk of having the metabolic syndrome (MetS) 
in men and in women. Values are Odds Ratios (OR) with 95% confidence interval (CI). Adjusted for 
age, smoking, alcohol consumption, education and VO2max. P-values are for trend. 
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Figure 10. Association of consumption of sausage with the risk of having the metabolic syndrome 
(MetS) in men and in women. Values are Odds Ratios (OR) with 95% confidence interval (CI). 
Adjusted for age, smoking, alcohol consumption, education and VO2max. P-values are for trend. 
 
5.2 DIET SCORE, CARDIORESPIRATORY FITNESS AND METABOLIC 
SYNDROME (STUDY II)  
5.2.1 Diet score and metabolic syndrome 
The prevalence of the metabolic syndrome was 38%, 27%, 25%, 21% and 17% among individuals 
achieving none, one, two, three or all four of the dietary goals, respectively. The risk of having 
metabolic syndrome was 40%, 47%, 57% and 66% lower among individuals achieving one, two, 
three and four goals, respectively, compared with those achieving none of the goals after 
adjusting for age and gender. Figure 11 shows the further adjusted results. The impact of further 
adjustment for smoking, alcohol consumption and education as well for VO2max tertiles on these 
associations was minimal. Further adjustments for medications, diseases, cognitive function and 
depression did not change these results (data not shown). 
5.2.2 Cardiorespiratory fitness and metabolic syndrome 
The prevalence of the metabolic syndrome was 47%, 24% and 8% among individuals in the low, 
middle and high VO2max tertiles, respectively. The risk of having the metabolic syndrome was 65% 
lower in the middle VO2max tertile and 91% lower in the high VO2max tertile than in the low VO2max 
tertile after adjusting for age and gender. As shown in Figure 12, further adjustments for smoking, 
alcohol consumption, education and diet score did not change these associations. In addition, 
these results remained after further adjustments for medications, diseases, cognitive function and 
depression (data not shown). 
 
5.2.3 Combination of diet score and cardiorespiratory fitness and metabolic syndrome  
The diet score and VO2max had an interaction for the risk of having metabolic syndrome after 
adjustment for age and gender (P=0.011). The magnitude of the interaction did not change after 
further adjustments (data not shown). 
The lowest prevalence of the metabolic syndrome (5%) was observed among individuals in the 
highest VO2max tertile and achieving 3-4 dietary goals, and the highest prevalence (55%) among 
those in the lowest VO2max tertile and achieving none of the dietary goals (Figure 13). The risk of 
having metabolic syndrome was 96% lower among those in the highest VO2max tertile and 
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achieving 3-4 dietary goals, 93% lower among those in the highest VO2max tertile and achieving 1-
2 dietary goals and 84% lower among those in the highest VO2max tertile but achieving none of the 
dietary goals than among those in the lowest VO2max tertile and achieving none of the dietary 
goals after adjusting for age and gender (Table 17). These associations did not change after further 
adjustments (data not shown). 
 
 
 
Figure 11. Independent association of diet score with the risk of having the metabolic syndrome 
(MetS). Values are Odds Ratios (OR) with 95% confidence interval (CI). Adjusted for age, gender, 
smoking, alcohol consumption, education and VO2max tertiles. 
 
 
Figure 12. Independent association of cardiorespiratory fitness (VO2max, ml/kg/min) with the risk of 
having the metabolic syndrome (MetS). Values are Odds Ratios (OR) with 95% confidence interval 
(CI). Adjusted for age, gender, smoking, alcohol consumption, education and diet score. 
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Table 17. Combined associations of diet score and cardiorespiratory fitness (VO2max, ml/kg/min) with 
the risk of having metabolic syndrome. 
 
  Diet score a 
  0 1-2 3-4 
VO2max tertiles b Low 1.00 (reference) 0.69 (0.42–1.13) 0.76 (0.43–1.37) 
 Middle 0.47 (0.25–0.89) 0.26 (0.16–0.43) 0.16 (0.08–0.31) 
 High 0.16 (0.07–0.37) 0.07 (0.04–0.14) 0.04 (0.02–0.10) 
Numbers are odds ratios (95% CI) from logistic regression analyses, adjusted for age and gender. 
aNumber of achieved dietary goals; bAge and gender specific VO2max tertiles. Abbreviations: VO2max = 
maximal oxygen uptake (ml/kg/min). 
 
 
 
Figure 13. Prevalence of the metabolic syndrome according to age and gender specific VO2max tertiles 
and diet score (=number of achieved dietary goals). Abbreviations: MetS = Metabolic syndrome; 
VO2max = maximal oxygen uptake (ml/kg/min). 
 
5.3 THE NORDIC DIET AND COGNITIVE FUNCTION (STUDY III) 
At baseline, 11% in men and 10% in women of the DR’s EXTRA participants were classified as 
having mild cognitive impairment. At the four-year examinations, the prevalence of mild 
cognitive impairment was 11% in men and 8% in women. The incidence of mild cognitive 
impairment was 5% in men and 4% in women at the four-year examinations.  
There were several differences in basic characteristics between women above and below 
gender-specific median of the Nordic diet score (Table 18).  In contrast, men with poor and good 
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adherence to the Nordic diet differed only in anthropometric measurements, serum cholesterol 
levels and VO2max (Table 18). Food consumptions and nutrient intakes according to the adherence 
to the Nordic diet at baseline are described in Table 19. 
 
 
Table 18. Basic characteristics in women and men according to adherence to the Nordic diet at 
baseline. 
 Men Women 
 Poor 
(n=314) 
Good 
(n=253) 
P-value Poor 
(n=279) 
Good 
(n=294) 
P-value 
Age (years) 65.9 (5.5) 66.0 (5.0) n.s. 67.0 (5.3) 65.5 (4.9) <0.001 
Education (years) 11.2 (4.1) 11.3 (3.8) n.s. 10.6 (3.4) 12.2 (3.8) <0.001 
Weight (kg) 84.9 (13.8) 82.6 (12.9) 0.042 71.2 (12.5) 69.2 (12.0) 0.055 
Height (cm) 174 (6) 174 (6) n.s. 159 (6) 161 (6) <0.001 
Body mass index (kg/m2) 28.1 (3.9) 27.2 (3.9) 0.008 28.0 (4.6) 26.7 (4.5) <0.001 
Waist circumference (cm) 100.1 (11.0) 97.0 (10.8) 0.001 89.8 (12.4) 86.4 (12.4) 0.001 
Serum total cholesterol 
(mmol/l) 
5.0 (1.0) 4.8 (0.9) 0.026 5.3 (0.9) 5.2 (0.9) n.s. 
Serum LDL cholesterol 
(mmol/l) 
3.2 (0.9) 3.1 (0.8) 0.041 3.3 (0.9) 3.2 (0.8) n.s. 
Serum HDL cholesterol 
(mmol/l) 
1.5 (0.4) 1.5 (0.4) n.s. 1.8 (0.5) 1.9 (0.5) 0.030 
Serum triglycerides 
(mmol/l) 
1.4 (0.7) 1.3 (0.8) n.s. 1.3 (0.6) 1.2 (0.6) 0.026 
Plasma glucose (mmol/l) 6.1 (1.3) 5.9 (0.9) n.s. 5.7 (0.9) 5.5 (0.6) <0.001 
Systolic blood pressure 
(mmHg) 
144 (19) 145 (19) n.s. 151 (21) 148 (20) n.s. 
Diastolic blood pressure 
(mmHg) 
84 (9) 84 (9) n.s. 82 (9) 82 (9) ns.s 
Smoking, never/ past/ 
current (%) 
36/48/16 36/54/10 n.s. 73/17/10 76/20/4 0.016 
CERAD total score 
(points) 
81.7 (9.5) 82.7 (8.6) n.s. 83.5 (8.7) 85.3 (7.5) 0.009 
MMSE (points)a 28.0 (2.0) 28.0 (2.0) n.s. 28.0 (3.0) 28.0 (2.0) 0.003 
Symptoms of depression 
(points)a, b 
7.0 (9.0) 6.0 (7.0) 0.077 9.0 (8.0) 8.0 (7.0) 0.057 
VO2max (ml/kg/min) 26.2 (6.1) 27.9 (6.2) 0.001 20.4 (4.5) 22.1 (5.0) <0.001 
Values are mean (SD) or amedian (IQR). P-values are from t-test, Mann-Whitney’s U test or 2-test. 
bAssessed by the Center for Epidemiological Studies Depression Scale (267). Abbreviations: n.s. = a 
statistically nonsignificant association; CERAD = the Consortium to Establish a Registry for 
Alzheimer’s Disease neuropsychological battery (268); MMSE = the Mini-Mental State Examination 
(153); VO2max = maximal oxygen uptake. 
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Table 19. Food consumption and nutrient intake according to the adherence to the Nordic diet at 
baseline in women and men. 
 Men Women 
 Poor 
(n=314) 
Good 
(n=253) 
P-value Poor 
(n=279) 
Good 
(n=294) 
P-value 
Nordic diet score 
(points)a 
9.0 (3.0) 14 (3.0) <0.001 8.0 (3.0) 13.5 (3.0) <0.001 
Change in Nordic diet 
score during 4 years 
(points)b 
1.3 (3.5) -2.2 (3.4) <0.001 1.9 (3.6) -1.6 (3.6) <0.001 
Vegetablesc (g/day)  126 (76) 199 (104) <0.001 144 (75) 232 (105) <0.001 
Fruit and berries (g/day)a 143 (147) 261 (197) <0.001 173 (131) 251 (177) <0.001 
Fish (g/day)a 23.6 (56.1) 59.8 (67.6) <0.001 17.7 (42.3) 49.2 (44.6) <0.001 
Whole grain bread 
(g/day) 
107 (61) 152 (78) <0.001 73 (36) 101 (44) <0.001 
Meat (g/day) 154 (79) 135 (80) 0.006 106 (52) 87 (49) <0.001 
Alcohol (g/day)a 3.1 (18.0) 3.7 (14.0) n.s. 0.0 (4.0) 0.0 (4.0) n.s. 
Energy (MJ/day) 7.5 (1.9) 8.8 (1.9) <0.001 5.8 (1.2) 6.6 (1.3) <0.001 
Energy (kcal/day) 1793 (443) 2100 (444) <0.001 1390 (288) 1567 (320) <0.001 
Protein (E%) 17.8 (3.0) 17.8 (2.8) n.s. 18.4 (2.8) 18.4 (2.8) n.s. 
Carbohydrates (E%) 44.5 (8.6) 46.9 (6.7) <0.001 47.4 (6.6) 48.7 (6.0) 0.016 
Fat (E%) 31.5 (6.6) 31.7 (5.4) n.s. 30.9 (5.9) 30.0 (5.2) 0.055 
SFA (E%) 12.3 (3.1) 10.6 (2.7) <0.001 12.4 (3.1) 10.4 (2.6) <0.001 
MUFA (E%) 10.5 (2.7) 10.6 (2.4) n.s. 10.0 (2.3) 10.2 (2.4) n.s. 
PUFA (E%) 5.2 (1.3) 6.2 (1.4) <0.001 4.9 (1.3) 5.9 (1.6) <0.001 
α-linolenic acid (g/day) 1.6 (0.6) 2.4 (0.9) <0.001 1.2 (0.5) 1.8 (1.0) <0.001 
UFA / total fat –ratio 0.56 (0.06) 0.62 (0.06) <0.001 0.5 (0.1) 0.6 (0.1) <0.001 
Dietary fibre (g/4.18 MJ) 12.1 (3.8) 14.3 (3.9) <0.001 13.0 (3.0) 15.9 (3.9) <0.001 
Values are mean (SD) or amedian (IQR). P-values are from t-test or Mann-Whitney’s U test. 
bComplete data were available for 563 men and 569 women. cIncluding roots, non-root vegetables, 
mushrooms, legumes and nuts, but not potatoes. Abbreviations: E% = percents of total energy 
intake; MUFA = monounsaturated fatty acids; n.s. = a statistically nonsignificant association; PUFA 
= polyunsaturated fatty acids; SFA = saturated fatty acids.  
 
 
During four years, the CERAD-TS improved from [mean (SD)] 82.2 (9.0) to 82.9 (10.4) points 
(P=0.015) in men and from 84.6 (7.9) to 86.1 (9.3) (P<0.001) in women. MMSE did not change 
during the four-years in either men or women. The total Nordic diet score did not change in the 
total cohort [median (IQR) 11.0 (6.0) points at baseline and 11.0 (5.0) points after four years]. 
However, the score improved in men and women with poor adherence to the Nordic diet score 
at baseline, and decreased in those with good adherence (Table 20). In addition, in men, increased 
consumption was observed in the amounts of fruit and berries [from median (IQR) 196 (199) to 
209 (221) g/day, P=0.025], and in α-linolenic acid [from mean (SD) 1.9 (0.9) to 2.1 (1.0) g/day, 
P=0.001] whereas a decline was noted in the consumption of alcohol [from median (IQR) 3.1 (15.0) 
to 0.9 (10.0) g/day, P<0.001]. In women, increased consumption was observed in the amounts of 
fruit and berries [from median (IQR) 218 (170) to 251 (166) g/day, P<0.001], whole grain bread 
[from mean (SD) 88.2 (43.2) to 92.9 (46.1) g/day, P=0.024] and fish [from median (IQR) 34.0 (4.0) 
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to 41.6 (48.8) g/day, P=0.043], and in α-linolenic acid [from mean (SD) 1.5 (0.8) to 1.8 (1.0) g/day, 
P<0.001] whereas a decline was noted in the consumption of alcohol [from median (IQR) 0.0 (4.0) 
to 0.0 (2.0) g/day, P<0.001]. 
At baseline, the adherence to the Nordic diet was not associated with CERAD-TS, its subtests 
or MMSE in either men or women (data not shown). The Nordic diet score at baseline was 
positively associated with the CERAD-TS at four-years in women but not in men (Table 20). After 
adjustment for energy intake, the association in women was also no longer statistically 
significant. However, the Nordic diet score at baseline was associated with the MMSE at four-
years in men but not in women (Table 20). Further adjustment for the energy intake did not affect 
these associations. Further adjustment for the change in the Nordic diet score and in the VO2max 
strengthened the association between the baseline Nordic diet and CERAD-TS at four-years in 
women, but did not change any of the other associations (Table 21).  
The Nordic diet score at baseline was positively associated with two subtests of the CERAD-
TS at four-years in women, but not with any subtests in men. In women, the Nordic diet score at 
baseline was positively associated with performance in the Word List Learning at four-years in 
Model 1 [β 0.12 (95% CI 0.05 - 0.19), P<0.001], in Model 2 [0.10 (0.04 – 0.17), P=0.003], in Model 3 
[0.08 (0.00 – 0.15), P=0.042] and in Model 4 [0.14 (0.05 – 0.22), P=0.002]. In addition, a positive 
association was found with Word List Recall in Model 1 [β 0.04 (95% CI 0.00 - 0.07), P=0.037], in 
Model 2 [0.04 (0.00 – 0.07), P=0.039] and in Model 4 [0.06 (0.02 – 0.10), P=0.007], but not in Model 
3 [0.02 (-0.01 – 0.06), P=0.188]. 
Taken together, these results indicate that better adherence to the baseline Nordic diet is 
associated with better scores in CERAD-TS and its two subtests Word List Learning and Word 
List Recall at four-years in women, and with better scores in MMSE at four-years in men. 
 
 
Table 20. Association of the baseline Nordic diet score with the CERAD total score and MMSE after the 
four-year follow-up in men and women. This table shows the change (β, 95% CI) in four-year cognitive 
scores with one point improvement in the baseline Nordic diet score. 
 
 Men (n=567) Women (n=573) 
 β 95% CI P value β 95% CI P value 
CERAD-TS      
Model 1 0.03  -0.11 – 0.17 n.s. 0.21 0.07 – 0.35 0.004 
Model 2 0.01 -0.14 – 0.16 n.s. 0.20 0.05 – 0.34 0.008 
Model 3  0.02 -0.14 – 0.18 n.s. 0.13 -0.02 – 0.28 0.096 
Model 4a 0.04 -0.15 – 0.22 n.s. 0.27 0.09 – 0.46 0.003 
MMSE       
Model 1 0.06 0.02 – 0.10 0.004 0.00 -0.04 – 0.04 n.s. 
Model 2 0.05 0.01 – 0.10 0.016 0.01 -0.03 – 0.05 n.s. 
Model 3 0.06 0.02 – 0.11 0.010 -0.02 -0.06 – 0.02 n.s. 
Model 4a 0.06 0.00 – 0.11 0.034 -0.01 -0.06 – 0.04 n.s. 
Values are from ANCOVA. Model 1: Age, education, study group and baseline CERAD total score. Model 
2: Model 1 + symptoms of depression, smoking, VO2max (ml/kg/min), antihypertensive medication, 
lipid lowering medication and antidiabetic medication. Model 3: Model 2 + energy intake. Model 4: 
Age, education, baseline CERAD total score, symptoms of depression, smoking, antihypertensive 
medication, lipid lowering medication, antidiabetic medication, energy intake, changes in Nordic diet 
score and VO2max from baseline to four-years. aComplete data were available for 549 men and 538 
women. Abbreviations: CERAD-TS = total score of the Consortium to Establish a Registry for 
Alzheimer's Disease neuropsychological tests (269); MMSE = the Mini-Mental State Examination 
(153); n.s. = a statistically nonsignificant association. 
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6 Discussion 
6.1 SUMMARY OF MAIN FINDINGS 
In the present thesis, the focus was to contribute to the knowledge about independent and 
combined associations of different dietary components and cardiorespiratory fitness with the 
metabolic syndrome and cognitive function. The main findings of this population-based study 
among middle-aged and elderly men and women are as follows: 
 
 Consumption of berries, legumes and nuts, and fish was inversely associated with the risk 
of having the metabolic syndrome in men. Consumption of sausage was directly 
associated with the risk of having metabolic syndrome in women. VO2max was a strong 
confounding factor in the association between food consumption and metabolic 
syndrome.  
 Both a healthy diet and higher levels of VO2max were independently associated with a 
reduced risk of having the metabolic syndrome. The association of VO2max with the 
metabolic syndrome was evident in all diet score groups, whereas the diet score was 
associated with the metabolic syndrome only among those in middle or high VO2max 
tertiles. This observation suggests that low VO2max is such a strong risk factor for the 
metabolic syndrome that even consuming a healthy diet cannot diminish the risk. 
 The baseline Nordic diet was positively associated with the global cognition assessed by 
CERAD-TS and two subtests assessing ability to learn new information and memory in 
women after four years.  In men, the baseline Nordic diet was positively associated with 
global cognition assessed by MMSE after four years.  
6.2 METHODOLOGICAL ASPECTS 
6.2.1 Study population and designs 
This doctoral thesis was part of a four-year randomized controlled trial, the DR’s EXTRA Study, 
which was designed to study the effects of regular physical activity and healthy diet on 
atherosclerosis, endothelial function and cognition. The study participants were a representative 
population based random sample of middle-aged and elderly men and women, which makes the 
results more generalizable. Individuals with diseases or conditions, judged by the research 
physicians, to have prohibited safe engagement in exercise training or co-operation were 
excluded. Approximately 70% of the randomly selected population sample was willing to 
participate in the study (Figure 4). One third of those who showed interest in participating were 
lost during the run-in-phase and baseline examinations due to various reasons, such as health 
problems, moving elsewhere or loss of motivation. Thus, individuals who participated in the 
entire study could be speculated to be healthier and more motivated to adopt a healthy lifestyle 
than non-participants. The drop-out rate during the intervention was low (15%) taking into 
consideration the long and demanding intervention period. The drop-outs were older and had 
more cardiometabolic risk factors, worse cognition, unhealthier diet and lower VO2max compared 
to the participants. All these issues may have diluted the potential effects of diet and 
cardiorespiratory fitness on metabolic syndrome and cognition. 
Both studies with the metabolic syndrome as an outcome were cross-sectional. In Study III, the 
study groups were pooled in the analyses and the study design can be considered to represent a 
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four-year follow-up. Thus, the possibility that changes in lifestyle factors during the intervention 
have affected the observed associations cannot be ruled out, even though the analyses were 
adjusted for the randomized study group.  
Food consumption and nutrient intake in the study population at baseline were similar to adult 
Finnish population (281) and were mainly in accordance with the Finnish nutrition 
recommendations (282) in terms of the mean values. However, inspection as percentages to 
achieve the recommendations revealed the polarisation of food consumption. There was an 
approximately equal number of individuals who achieved and those not reaching the nutrition 
recommendation in the DR’s EXTRA study population. It is illustrative and worthwhile 
expressing both mean values and percentages of individuals achieving the recommendations. 
Thus, even though it appeared that the food consumptions and nutrient intakes as mean values 
were at the recommended level, inspection as percentages showed that every other participant 
had room for improvement in the diet. 
Similarly to the diet, the mean level of aerobic physical activity at baseline was in accordance 
to the physical activity guidelines (110). However, if one calculates the values as percentages of 
individuals who are achieving the recommendations, then it is apparent that there is also a 
polarisation of aerobic physical activity i.e. half of the participants did not meet the guidelines. 
In addition, resistance exercise was uncommon in the study population at baseline with less than 
1% reporting that they were doing this kind of exercise. The low number of participants 
participating in resistance exercise is alarming since these kinds of muscle-strengthening 
activities are essential for the maintenance of muscle mass and muscle strength (Table 5 in 
Appendices). During ageing, the human body undergoes many changes including alterations in 
body composition leading to a loss of muscle mass (283). In general, these are normal age-related 
processes which everyone experiences to some extent. However, loss of muscle mass can 
predispose elderly individuals to frailty which increases the risk of dependency, morbidity and 
mortality (284). In the present study, the resistance exercise included only training at a gym. Thus, 
other muscle-strengthening activities, such as heavy gardening or carrying heavy loads, were not 
included.  
 
6.2.2 Assessment of dietary intake 
One strength of all original studies is that dietary intake was assessed by a four-day food record. 
Usually dietary intake in studies with larger number of participants has been assessed only with 
food frequency questionnaires, as was the case in the studies reporting associations of diet with 
the metabolic syndrome or cognitive function. A four-day food record is an open-ended dietary 
assessment method fillied in at the time that the foods are being eaten, thus it does not rely on 
memory and in that respect is superior to the more commonly used retrospective food frequency 
questionnaires or recalls (285). The accuracy of all dietary assessment methods are highly 
dependent of the respondents’ motivation and ability to report their food consumption. A decline 
in ability to receive and process the information may be affected in cognitive impairment (129), 
which in turn would probably impair the ability to record the food intake, irrespective of which 
methodology is used. In addition, keeping a food record may lead to changes in eating due to the 
individualsʼ willingness to lighten the burden of recording (285). Furthermore, one could 
speculate that some people may provide what they think are socially acceptable answers which 
introduces bias into the values. Usually consumption of foods and drinks considered unhealthy 
are underreported whereas those considered healthy are reported similarly among 
underreporters and non-underreporters (286). Thus, underreporting of dietary intake is a 
common source of error in the case of food records (285). This is especially evident among 
overweight and obese individuals (287) as well as in older individuals (288). Underreporting was 
evident in the DR’s EXTRA study as well. According to the diaries, the subjects’ energy intakes 
were approximately 1890 kcal in men and 1470 kcal in women which are lower intakes than 
expected. 
65 
 
 
To enhance accuracy in the DR’s EXTRA study, the recording dates were defined by the 
researcher and were consecutive, including three weekdays and one weekend day, whenever 
possible. In addition, both verbal and written instructions were given and food records were 
checked and completed by a clinical nutritionist or a trained nurse when the diaries were 
returned. Seasonal variation in diet may not have been captured at an individual level; however, 
as the examination of the present study population was spread out over 1.5 years, it is unlikely 
that this has introduced any significant general bias. 
Although the diet score used in Study II was derived from the official nutrition 
recommendation of the American Diabetes Association (274), any diet score is a somewhat 
artificial and simplified description of overall dietary habits. In Eastern Finland, fish consumption 
is quite common. Therefore, more than half of the participants achieved the dietary goal of fish 
consumption. However, among the studied age group it is common to cook fish with butter or 
cream. Therefore, it was necessary to add SFA to the diet score to describe the quality of dietary 
fat. The recommended intake of dietary fiber is relatively easy to achieve due to a high 
consumption of whole grain bread in Eastern Finland. Consumption of vegetables, on the other 
hand, is generally low, and achieving that goal may reflect increased health awareness. Sodium 
intake is also a potential component of a healthy diet score. It was decided not to include sodium 
in the diet score, because the intake of added salt cannot be reliably assessed from diet records.  
The Nordic diet score used in the Study III has some limitations. The contents of food groups 
used in the diet score were given by the nutrient calculation software (MicroNutrica®) (273). Thus, 
problematic food groups were fish and whole grain bread, which were classified as healthy ones, 
while unrecommended food items, e.g. processed fish products and biscuits, were also included. 
Despite the fact that meat was classified as an unrecommended food group, it is an important 
source of good quality protein, especially in the elderly, and thus meat can be a part of a healthy 
diet if low-fat choices are being used and meat consumed in moderate amounts. 
6.2.3 Assessment of cardiorespiratory fitness and physical activity 
Cardiorespiratory fitness is a surrogate measure of physical activity (24,25). Measurement of 
VO2max is more accurate, and thus a stronger predictor of different health outcomes, than self-
reported physical activity questionnaires (289). VO2max can be measured directly or estimated 
indirectly in a treadmill or cycle ergometer test (290). In the present study, direct measurement 
of VO2max during a symptom-limited, incremental cycle ergometer test was used. This is the most 
accurate and reproducible method with which to measure cardiorespiratory fitness (290). 
Furthermore, reproducibality in the present study was enhanced by providing the participants 
with standardized instructions on how to prepare for the test.  The bicycle ergometer test is a 
good and safe choice for middle-aged and older individuals since weight-bearing and balance 
are not needed. On the other hand, muscle weakness may limit the performance in a cycle 
ergometer before the VO2max is reached. However, effect of the muscle weakness can be minimised 
with small increases in workload, as was done in the present study. Maximality of the exercise 
test was evaluated with respiratory exchange ratio and perceived exertion. Even with these 
criteria, the evaluation of maximality is challenging, and thus the term symptom-limited VO2max 
was used. Direct measurement of VO2max is time-consuming, expensive, requires specialized 
equipment, supervisory personnel (e.g. physician and nurse), and is demanding for the 
participant since it requires maximal effort and good motivation.  
Physical activity during the past 12 months was assessed by a Finnish version of a Minnesota 
Leisure Time Physical Activity Questionnaire (278). To improve accuracy, the participants were 
briefed with verbal and written instructions on how to fill in the form. Furthermore, 
questionnaires were checked and completed by trained personnel when the form was returned. 
Due to the large number of participants, it was not feasible to use more accurate physical activity 
assessment methods, such as pedometers, accelerometers or heart rate monitors.   
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6.2.4 Outcome assessments 
The metabolic syndrome was defined by widely used, international, and clinically applicable 
NCEP criteria (54). In the latest definition issued by JIS (30), which attempts to unify the criteria 
for the metabolic syndrome, the threshold for blood glucose level has been lowered in 
comparison to the NCEP recommended value. More research is warranted to optimise the 
thresholds for waist circumference (30). Meanwhile, either thresholds of NCEP or IDF can be used 
for European people. While the existence of the metabolic syndrome has been questioned (291), 
the recent joint statement of the expert group agrees that focusing on multiple metabolic risk 
factors rather than on single risk factors separately makes it possible to identify a large number 
of individuals with an increased risk of cardiovascular diseases and diabetes (30). When the DRʼs 
EXTRA Study was initiated, the NCEP criteria were selected because it is widely used in research, 
is useful predicting type 2 diabetes and cardiovascular diseases and all of the needed variables 
could be readily acquired. The IDF criteria were available at that time but they had only recently 
been published whereas the JIS criteria only appeared years later.  
Cognitive function was evaluated by the CERAD neuropsychological battery (268), of which 
the CERAD-TS was calculated (269). The CERAD-TS is an accurate measure of global cognitive 
status in normal ageing and in the early stages of dementia. In addition, it has high test-retest 
reliability. The CERAD-TS is a more sensitive measure than the more commonly used MMSE or 
single CERAD subtests to discriminate individuals with mild cognitive impairment from healthy 
elderly subjects (279). The CERAD battery has been validated also in the Finnish population, and 
is recommended as an appropriate tool to screen Alzheimerʼs disease even in a primary health 
care (292). Age, education and gender affects on the performance in the CERAD battery (269), 
these factors were considered in the statistical analyses.  
In general, assessment of cognitive function is challenging since many factors influence the 
performance in neuropsychological tests (126). For example, culture, education, health status, 
medications and environmental factors all can affect test performance. Therefore, cognitive 
function not only varies between individuals but even within an individual from day to day (293). 
In addition, there is a large inter-individual variability in age-related cognitive changes. 
Performance in neuropsychological tests needs to be compared to some reference values to confer 
a meaning to the scores (126). At the individual level, it would be best to assess cognitive function 
several times, and observe the change in test scores. In addition, normative scores are commonly 
used in the estimation of cognitive function. These norms are usually controlled for age and 
education, and individual reference values should be defined for different cultures. However, it 
is impossible to control for all relevant factors, e.g. medications or health status, in these norms. 
Despite these limitations, these neuropsychological tests do provide reliable and relevant 
information about an individualʼs cognitive strengths and weaknesses, and can monitor time-
dependent changes cognitive function. 
 
6.3 INTERPRETATION OF FINDINGS AND COMPARISON TO OTHER STUDIES 
6.3.1 Diet and metabolic syndrome  
In the present thesis, consumption of berries, legumes and nuts and fish was beneficially 
associated with the risk of having the metabolic syndrome in men, and consumption of sausage 
harmfully in women. In addition, a healthy diet score was associated with a lower risk of having 
the metabolic syndrome independently of the value of VO2max. 
The association of consumption of fish (only in men), berries (only in men) and sausage (only 
in women) with the metabolic syndrome was gender-specific in the present study. Responses to 
diet may differ in men and women partly due to differences in metabolism and sex hormones 
(294). One other possible explanation for gender difference is distinctions in the diet quality. 
There were differences in the consumption of several food items in men with and without the 
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metabolic syndrome whereas consumption of food items was mainly similar in women with and 
without the metabolic syndrome. For example, men with the metabolic syndrome consumed on 
average 26 g of berries, and 3 g of legumes and nuts every day, whereas men without the 
syndrome consumed double these amounts. Thus, it is easier to capture associations between diet 
and metabolic syndrome in men than in women due to the larger variations present in the male 
diet. 
In addition, the way of using food items differs between men and women. For example, 
women were more likely than men to consume berries within energy-dense bakery products. 
Thus, the increased energy intake due to bakery products may be a confounding factor and 
explain, at least in part, the failure to detect any association between berry consumption and the 
metabolic syndrome in women. Further, it is possible that certain food items indicate unhealthier 
or healthier food choices and lifestyle in general. It is possible that these so called lifestyle 
indicators are different in men and women. For example, a higher consumption of sausage in 
women may reflect an unhealthier lifestyle in general, whereas in men the overall consumption 
of sausage was relatively high. On the other hand, in men, the consumption of legumes and nuts 
may reflect a general healthier lifestyle. 
The data of gender-specific associations of diet and the metabolic syndrome are limited. For 
example, a gender-specific effect of fish consumption on the metabolic syndrome was found in 
the prospective observational study among middle-aged Korean individuals (90). In that study, 
consumption of fish only by men was beneficially associated with the metabolic syndrome. 
However, in another study conducted among Iranian women aged 30 or over, found a beneficial 
association between fish consumption and the metabolic syndrome in their cross-sectional design 
(89). Due to the limited data and contradictory findings, it is impossible to draw any final 
conclusions about gender-specific effects on the metabolic syndrome. 
Observations about the beneficial association of fish consumption with the risk of having the 
metabolic syndrome in men and harmful association of consumption of sausage in women were 
not unexpected and in line with previous studies (49,74,80,81,89,90). Both of these food items at 
least partly reflect the quality of dietary fat in the diet, which may be one explanation for the 
detected associations. In addition to healthy nutrient content, the beneficial effects of fish may be 
explained by the fact that it replaces meat in a main course. Thus, the associations may be due to 
either the fish itself or to the decreased consumption of meat.  
Cooking methods and type of meat and fish probably have an effect on responses in human 
body. Commercially prepared fish, e.g. fried fish filets, might be less beneficial than fresh fish 
since they have a poorer nutrient content (295). In the present study, “fish” included all fresh and 
processed fish sources because they could not be separated due to features of the used nutrient 
calculation software. In this age group of Finnish individuals it is common to cook fish with butter 
or cream. Therefore the present results may underestimate the true associations between fish 
consumption and the risk of having the metabolic syndrome. Furthermore, different sources of 
meat may have varying effects on cardiovascular health and mortality (296). Since sausages 
include several harmful nutrients, including SFA, sodium and nitrite, regular consumption of 
these products is most likely deleterious for health. In other sources of meat, such as pork, poultry 
and beef, low-fat choices are available and the amount of salt can be controlled in cooking. In 
addition, these are good sources of high-quality protein which is essential in maintenance of 
muscle mass, especially during ageing and weight loss (283). Thus, food items containing good-
quality protein, including low-fat meat and fish, can be part of a healthy diet if consumed in 
moderate amounts. 
A significant inverse association was found in men between a moderate consumption of 
berries and the metabolic syndrome, additional benefit occurring with an increased consumption 
but no similarassociation was found in women. Previously, the moderate consumption of berries 
has been associated with lower levels of blood pressure and higher serum concentrations of HDL 
cholesterol in middle-aged individuals with unmedicated cardiovascular risk factors (297). The 
present study indicates that increased berry consumption is inversely associated with the 
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prevalence of the metabolic syndrome, not only with single components of the syndrome. These 
findings support the concept of berries as domestic “super-foods”. No other plant sources, 
including vegetables and non-root vegetables, were associated with the risk of having metabolic 
syndrome in the present study after adjustment for VO2max. In general, a high consumption of 
vegetables is associated with a lower risk of cardiovascular diseases and mortality (61,298). From 
that perspective, the lack of an association in the present study was unexpected. However, in the 
context of the metabolic syndrome previous findings have been conflicting and only a few studies 
have been published (49,69).  
Since individuals eat whole meals, not just single food items or nutrients, it is important to 
explore the effect of dietary patterns on health. In the present study a simple healthy diet score 
had an inverse, graded association with the risk of having the metabolic syndrome which is in 
congruence with previous studies.  All factors in the diet score, including a high intake of fiber 
(70), a high consumption of fish (74,89,90) and vegetables (69) and a low intake of SFA (77), have 
previously been associated with a lower risk of the metabolic syndrome. Furthermore, in 
randomized controlled trials, the Mediterranean diet and the DASH diet have been shown to be 
effective in the treatment of the metabolic syndrome (50-52) although all the participants in these 
trials had metabolic syndrome (50,51) or cardiovascular risk factors (52). Thus, their results 
cannot be applied to prevention of the metabolic syndrome at a population level. However, in 
prospective cohort studies, good adherence to these diets have been associated with a lower 
incidence of the metabolic syndrome (46-48). Participants in the previous studies were younger 
than in the DR’s EXTRA Study. The analyses contained multiple adjustments, including physical 
activity. However, diet was assessed with food frequency questionnaires and physical activity 
with self-administered questionnaires which are less accurate methods than those used in the 
present study.  
One notable finding in the present thesis was that VO2max is a significant confounding factor in 
the associations between dietary factors and the metabolic syndrome. In previous studies, the 
associations between dietary factors with the metabolic syndrome data have been adjusted for 
self-reported physical activity instead of VO2max. 
 
6.3.2 Cardiorespiratory fitness and metabolic syndrome  
In the present thesis, VO2max was beneficially associated with the metabolic syndrome. This 
association was independent of a healthy diet and evident in all individuals irrespective of the 
quality of their diet. This observation suggests that a low VO2max value is a major risk factor for 
the metabolic syndrome. In previous studies, good VO2max has been protective against the 
development of the metabolic syndrome (100,102,103). Thus, the association found here is in 
agreement with those findings. The present study was cross-sectional but in the DR’s EXTRA 
study population, a good VO2max value has been shown to be protective against the development 
of the metabolic syndrome in a longitudinal setting as well (103). The previously published two 
studies were conducted in men only (100) or cardiorespiratory fitness was assessed indirectly by 
the duration of the maximal treadmill test (102) whereas in the DR’s EXTRA Study both genders 
were included and VO2max was directly measured. In addition, neither the study of Laaksonen et 
al. (100) nor LaMonte et al. (102) was controlled for diet, in contrast to the present study and that 
of Hassinen et al.  (103). 
 
6.3.3 Combined association of diet and cardiorespiratory fitness with the metabolic 
syndrome  
Limited data are available about the combined associations of diet and cardiorespiratory fitness 
with the metabolic syndrome. Previously, in a large cohort study low cardiorespiratory fitness 
seemed to be a stronger risk factor for all-cause mortality than an unhealthy diet (299). In a large 
population-based study, the risk of chronic diseases during a mean follow-up of eight years was 
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similar among those adhering only to either healthy diet or physical activity (300). Interestingly, 
the combined association of diet and physical activity was greater than was expected from the 
independent associations. In another population-based study from 11 European countries, the 
risk of all-cause, coronary and cardiovascular mortality during a 10-year follow-up was similar 
among those adhering either to a Mediterranean type diet or to physical activity (301). These 
results suggest that a healthy diet and physical activity have an equal impact on pre-mature 
mortality. It is noteworthy that physical activity and diet exerted an equal impact on mortality 
(300,301) whereas cardiorespiratory fitness showed a stronger association than diet (299). This 
may reflect the importance of good cardiorespiratory fitness. On the other hand, it should borne 
in mind that cardiorespiratory fitness is an objective measure of physical function whereas 
physical activity and diet are subjective assessments.  
Healthy diet, physical activity and good cardiorespiratory fitness are all beneficial for health. 
However, the question is still unanswered whether all of these are needed to minimize the risk 
of the metabolic syndrome. The intervention study conducted among middle-aged men with the 
metabolic syndrome indicates that an intervention involving the combination of the diet and 
physical activity was more effective in the treatment of the metabolic syndrome than either 
component alone (116). In the present study, the risk of having the metabolic syndrome was 
lowest among those with a healthy diet and good cardiorespiratory fitness which supports the 
hypothesis that both factors are needed for health promotion. However, in clinical practice even 
small changes toward a healthier lifestyle are most likely to be effective if changes are permanent. 
Thus, striving to adhere to a perfect diet or an intensive exercise schedule most probably is not 
needed, and minor but permanent changes in both lifestyle factors would be a sufficient goal. 
6.3.4 The Nordic diet and cognitive function  
The Nordic diet is based on typical local food items found in the Nordic countries, characterized 
by a high consumption of vegetables, fruit and berries, fish and whole grain products as well as 
low-to-moderate consumption of meat and alcohol, with rapeseed oil being the recommended 
source of fat (275). The majority of the Nordic diet score components have previously been 
associated with cognition. A high consumption of vegetables and fish as well as high intake of 
polyunsaturated fatty acids are postulated to protect against cognitive decline (163,302) whereas 
saturated fatty acids are inversely associated with cognition (163). Furthermore, omega-3 fatty 
acids have beneficial effects on mild cognitive impairment (205) and low-to-moderate alcohol use 
is associated with a reduced risk of dementia (303). However, the association of the Nordic 
dietary pattern with cognition have not previously been studied.  
Most of the studies examining the impacts of dietary patterns on cognition have exploited the 
Mediterranean type diet and most of them have found a decreased risk of having cognitive 
decline (137-139) and Alzheimerʼs disease (141), although these positive results have not been 
duplicated in all studies (142,144). With respect to the other dietary patterns, there are both 
positive (139,149) and neutral (138) findings related to cognitive decline and dementia in 
prospective observational studies. These types of inconsistent findings are not uncommon in 
nutrition science due to various reasons. Thus, several studies with reliable study designs are 
needed before one can draw conclusions. The existing data of the associations between dietary 
patterns and cognition are encouraging, and emphasize the importance of the same dietary 
factors affecting also the cardiovascular health. However, more data from randomized controlled 
trials will be needed to confirm effects of different dietary patterns on cognitive function during 
ageing. At present, the Mediterranean type diet has been the most widely studied dietary pattern 
in reference to cognitive function. However, most studies which have found a beneficial 
association with cognitive decline has been conducted in the USA, whereas studies from original 
Mediterranean countries have resulted in neutral findings. Based on these results, it is impossible 
to state definitely that the Mediterranean diet can reduce the risk of cognitive decline. These 
results emphasize that a diet with the features of the Mediterranean diet is beneficial. 
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In the present study, the better adherence to the baseline Nordic diet was associated with the 
higher scores in global cognition in men and women, and in two subtests, assessing delayed 
memory and the ability to learn new information, in women over the four-year study period after 
the adjustment for demographic and lifestyle factors. However, after adjustment for dietary 
energy intake, some of the associations found between the Nordic diet and cognition were no 
longer statistically significant.  
There are sources of bias in the adjustment for the energy intake, which should be considered 
before drawing any final conclusions. Underreporting of energy intake is a common source of 
error in nutritional assessments as discussed in chapter 6.2.2. In addition, undereating is more 
common in the elderly and this has been observed in nutrition assessments as lower energy 
intakes and resulted in a decline in body fat and muscle mass (304). This phenomenon, known as 
anorexia of ageing, has serious consequences such as decline in functional capacity, nutritional 
deficiencies, a decline in cognitive function, even premature death. In the present study, the 
energy intake was lower among individuals with impaired cognition compared to those with 
normal cognition, likely due to both underreporting and undereating. In support of the 
possibility that there was undereating, individuals with impaired cognition at baseline lost 
approximately one kilogram more body weight than those with normal cognition during four-
years (data not shown). Thus, these results may reflect the overall importance of diverse diets 
providing sufficient amount of energy to maintain energy balance and prevent malnutrition, and 
further reduce cognitive decline, during ageing. 
One unexpected observation was the gender-specific association of the Nordic diet and 
cognitive function. In women, the Nordic diet was associated with cognitive function when this 
was assessed only by the CERAD test battery, whereas in men, the association was observed only 
with MMSE. There are no clear explanations for this difference, thus, reasons can only be 
speculated. In general, women with poor adherence to the Nordic diet at baseline had a worse 
risk factor profile than women with good adherence. In contrast, men with either poor or good 
adherence to the Nordic diet displayed only some differences in basic characteristics. Another 
explanation could be that the age-related cognitive decline might be different in men and women. 
Even though the CERAD total score and MMSE both assess global cognition, they might well 
assess different aspects of cognitive function. If the nature of the cognitive decline is gender-
specific, the changes might be captured with different assessment methods in men and women. 
In future studies striving to answer these unanswered questions, associations between diet and 
cognitive function should be explored separately in men and women. 
The cognitive function was maintained during the four-year study period. In the longitudinal 
studies, declines in cognitive function are typically minor (305) or in some cases, cognition may 
even improve (306). One potential explanation in the present study is that the participation into 
the intervention study led to improvements in the lifestyle factors as well as providing social and 
mental stimulation. Cognitive tests were performed three times during the study, thus a learning 
effect might have led to a better performance in the tests, similarly to the findings in other studies 
(305,306). The retest effect may introduce bias into these results by underestimating the age-
related cognitive decline. It should also kept in mind that the progression from normal cognition 
to dementia may require several decades (11), thus there may be limitations on the ability to 
detect clinically relevant changes in cognition over a four-year period. Since changes in cognition 
may be minor, it may also be difficult to reveal the effects of diet. Thus, even a small improvement 
in cognition attributable to diet may be clinically relevant. 
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6.4 UNDERLYING PHENOMENA 
6.4.1 Diet, cardiorespiratory fitness and metabolic syndrome 
As discussed above, different nutrients, food items, physical activity and cardiorespiratory fitness 
are associated with the metabolic syndrome. The underlying mechanism may be driven by the 
accumulation of visceral and ectopic fat to the liver and skeletal muscles thus causing the insulin 
resistance (34). Thus, weight loss is the primary therapy for prevention and management of the 
metabolic syndrome (45). A healthy diet and physical activity are key factors in the weight 
management (307) and thus in the maintenance of normal fat content in the liver, skeletal muscles 
and pancreas (308). Weight loss with diet alone or in combination with physical activity is more 
effective than physical activity on its own (307). However, increased energy expenditure by 
increasing physical activity reduces the visceral fat even in cases where there is no weight 
reduction (309). One explanation may be that aerobic exercise enhances glucose uptake and 
glycogen synthesis in skeletal muscle and secondarily reduces lipogenesis in the liver in the 
postprandial condition (310). Thus, both a healthy diet and regular physical activity are important 
in preventing ectopic fat accumulation, insulin resistance and metabolic abnormalities. 
In the elderly, the need to achieve weight loss needs to be be carefully assessed. In the 
individuals over 60 years of age, the recommended BMI is 24-29 kg/m2 because lower values are 
associated with higher mortality (311). During ageing, the human body undergoes many changes 
including alterations in cerebral structure and functionality, body composition and metabolism 
(283,284). Mainly these are normal age-related phenomena which everyone experiences to some 
extent. However, these changes predispose elderly individuals to frailty which then increases the 
risk of social dependency, morbidity and mortality (284). The age-related body changes can be 
postponed or at least slowed down through modifiable factors such as diet and physical activity 
(283). Both aerobic and resistance exercise are essential for the maintenance of muscle mass, 
muscle strength and cardiorespiratory fitness during ageing. In addition, adequate energy and 
protein intake are necessary to maintain an optimal body composition. Therefore, in the 
prevention of the metabolic syndrome, the quality and amount of foods eaten and physical 
activity are crucial, especially in the elderly. 
Many aspects of the effects of diet and physical activity on the metabolic syndrome and its 
components are mediated through body adiposity. However, several of these factors can 
influence other components of the metabolic syndrome independently of body adiposity (Figure 
14). For example, modification of dietary fat quality by replacement of SFA with MUFA or PUFA 
improves insulin sensitivity (76) and has beneficial effects on the plasma lipid profile (75,312). In 
addition, a sufficient intake of long-chain fatty acids EPA and DHA can reduce blood levels of 
triacylglycerols (75,312) highlighting the importance of weekly consumption of fish. Dietary fiber 
has beneficial effect on insulin sensitivity (313,314) and dyslipidemia (315). The effects on the 
blood lipid profile are mainly due to soluble dietary fiber, from fruit, berries and legumes, and in 
whole grain products, oats and barley in particular. Decreased consumption of alcohol results in 
a reduction of blood triacylglycerol levels (316). Furthermore, the combination of whole grain 
products, fatty fish and bilberries has been reported to improve glucose metabolism in 
individuals with the features of the metabolic syndrome (317). In addition, a dietary pattern 
involving high consumption of vegetables and low-fat dairy products as well as a low intake of 
sodium and SFA is efficient in the prevention of hypertension (23). These kinds of healthy dietary 
patterns also dampen down low-grade inflammation (51,318,319).  
Physical activity can reduce all of the components contributing to the metabolic syndrome. 
Both aerobic and resistance type of physical activity improve insulin sensitivity and glucose 
metabolism (310,320), and blood pressure (321). In particular, moderate-to-high intensity physical 
activity which improves cardiorespiratory fitness is the most efficient. With regular aerobic 
physical activity all components of dyslipidemia (i.e. levels of HDL- and LDL-cholesterol and 
triacylglycerols) can be beneficially affected (322,323).  
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6.4.2 Diet, cardiorespiratory fitness and cognitive function 
Clear mechanisms explaining the beneficial effects of healthy diet, physical activity and good 
cardiorespiratory fitness on cognitive function have not yet been demonstrated (324,325). 
However, it is likely that these effects on cognition are mediated through their beneficial effects 
on vascular risk factors, inflammation and oxidative stress (Figure 14). As discussed above, 
several food items and nutrients and physical activity counteract vascular risk factors. In 
addition, a healthy diet as well as physical activity reduce the risk of stroke (326,327), 
cardiovascular diseases (327-329) and type 2 diabetes (16,17), and these improvements, at least 
partly, prevent the risk of suffering cognitive impairment and dementia  
A healthy diet is one rich in nutrients postulated to protect brain health. There are claims that 
the flavonoids in fruits and berries might confer protection to neurons against neurotoxins and 
neuroinflammation, activate synaptic signalling and improve blood flow in brain (330). In 
addition, it has been speculated that a good dietary intake of flavonoids and other antioxidants, 
such as vitamin E, vitamin C and carotenoids, could protect the brain from oxidative stress (331). 
Omega-3 fatty acids, especially EPA and DHA from fish, may protect tissues against 
inflammation and oxidative stress, and provide larger gray matter volume as well as influencing 
neuronal membrane properties affecting neurotransmission and synaptic plasticity (331). In 
addition, high intake of dietary omega-3 fatty acids has been associated with lower plasma levels 
of β-amyloid (332) which is a surrogate marker of β-amyloid deposition in the brain. 
Higher levels of physical activity are associated with lower levels of β-amyloid in plasma and 
in brain as assessed by positron emission tomography (325). In addition, good cardiorespiratory 
fitness has been associated with larger brain volumes and reduced brain tissue loss (226). Thus, 
level of brain atrophy may be reduced by regular physical activity. Furthermore, physical activity 
may increase levels of crucial growth factors e.g. brain-derived neurotrophic factor which is 
involved in growth and in the survival of neurons (325). 
  
73 
 
 
 
 
Figure 14. Some possible mechanisms of the effect of diet, physical activity and cardiorespiratory 
fitness on vascular health and cognition. Modified from Obisesan et al. (333). Abbreviations: CRP = 
C-reactive protein; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein 
cholesterol. 
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Weight 
management 
Visceral and 
ectopic fat ↓ 
Muscle mass ↑ 
 
Increase 
formation of HDL-
β-amyloid -
complex  
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7 Conclusions and future implications 
7.1 CONCLUSIONS 
This doctoral thesis suggests that a healthy diet in line with existing guidelines is associated with 
a lower risk of having the metabolic syndrome and in preventing the development of cognitive 
decline. In practice, the recommended diet is one consisting of vegetables and whole grain 
products daily with fish consumed at least twice a week, and preferring sources of unsaturated 
fatty acids instead of saturated fatty acids. One such diet is the Nordic diet, which is suitable and 
practical for Finnish individuals. 
Furthermore, good cardiorespiratory fitness seems to be a strong protective factor against 
developing the metabolic syndrome. In practice, this finding emphasizes the importance of 
regular physical activity of at least moderate intensity. 
The associations of diet and cardiorespiratory fitness with the metabolic syndrome or cognitive 
function were independent of each other. In addition, an additional benefit towards a lower risk 
of having the metabolic syndrome was observed by adhering to a healthy diet and enjoying good 
cardiorespiratory fitness. Therefore, the present doctoral thesis highlights the importance of both 
diet and physical activity in the maintenance of cardiovascular and brain health during ageing. 
7.2 FUTURE IMPLICATIONS 
Based on the findings emerging from this thesis, the effect of the Nordic diet on cognitive function 
is promising and thus should be studied in other populations. In addition, it is recommended 
that the findings about the combined associations of diet and cardiorespiratory fitness with the 
metabolic syndrome should be replicated in other studies. 
The importance of the cardiorespiratory fitness in health promotion is well documented. 
However, one aim of the future studies will be to identify the best mode of physical activity to 
promote health. More studies will be needed to determine whether aerobic, resistance or a 
combination of those exercise modes is the most effective way to maintain cardiovascular and 
brain health. In addition, it will be important to evaluate the optimal intensity of these physical 
activities and to clarify the role of sedentary time in high quality studies.  
Diet, physical activity and cardiorespiratory fitness are important, but still only single pieces 
in a larger cluster of factors affecting cardiovascular and cognitive health. Thus, multi-domain 
intervention studies will be needed if we are to find successful actions to prevent these chronic 
diseases. Indeed, initial results from the first multi-doman intervention study including diet, 
exercise, cognitive training and vascular risk monitoring have been promising, suggesting that 
cognitive function can be improved in at-risk elderly individuals (334). However, these findings 
will need to be replicated in other populations before it is possible to translate these concepts into 
clinical practice.  
The duration of the intervention and the target groups will need to be carefully selected in the 
future studies. One would predict that high-risk individuals would benefit most from the lifestyle 
interventions. Further, it is likely that individual responsiveness to diet and physical activity, due 
to variability in genetics, diseases, lifestyle and environment plays a role in the prevention of 
chronic diseases. In the future, the accumulating knowledge of lifestyle-gene–interactions may 
make possible the concept of provision of personalized diet and physical activity 
recommendations. However, though that may be in the future, today all individuals should adopt  
a healthy diet in line with existing guidelines and make sure they take regular physical activity; 
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these are the primary actions that an individual can undertake to prevent cardiovascular diseases 
and cognitive impairment. 
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Appendices 
Table 1. Diagnostic criteria for the metabolic syndrome. 
 
Component 
of MetS 
WHO 1999 NCEP 2001 IDF 2005 AHA/NHLBI 
2005 
JIS 2009 
Insulin 
resistance 
IGT, IFG, T2DM 
or lowered 
insulin 
sensitivity and 
any 2 of the 
following 
 
None, but any 
3 of the 
following 
- None, but any 3 
of the following 
None, but any 
3 of the 
following 
Body weight Waist-to-hip 
ratio in men 
>0.90, in 
women >0.85 
and/or BMI>30 
Waist 
circumference 
≥102 cm in 
men, ≥88 cm in 
women 
Increased waist 
circumference 
(population 
specific, e.g. for 
Europeans ≥94 
in men, ≥80 in 
women) and 
any 2 of the 
following 
 
Waist 
circumference 
≥102 cm in men, 
≥88 cm in 
women 
Increased waist 
circumference 
(population and 
country specific, 
e.g. for 
Europeans 
either the IDF 
or AHA/NHLBI 
cut points) 
Triglycerides ≥1.7 mmol/l  ≥1.7 mmol/l ≥1.7 mmol/l or 
TG lowering 
medication 
 
≥1.7 mmol/l or 
TG lowering 
medication 
≥1.7 mmol/l or 
TG lowering 
medication 
HDL-
cholesterol 
<0.91 in men, 
<1.01 in women  
<1.03 in men, 
<1.29 in 
women  
<1.03 in men, 
<1.29 in women 
or medication 
for low HDL-C 
 
<1.03 in men, 
<1.29 in women 
or medication for 
low HDL-C 
<1.0 in men, 
<1.3 in women 
or medication 
for low HDL-C 
Blood 
pressure 
≥140/90 mmHg 
 
≥130/85 mmHg  ≥130/85 mmHg 
or 
antihypertensive 
medication 
 
≥130/85 mmHg 
or 
antihypertensive 
medication 
≥130/85 mmHg 
or 
antihypertensive 
medication 
Glucose  IGT, IFG or 
T2DM 
≥6.1 mmol/l ≥5.6 mmol/l ≥5.6 mmol/l or 
antidiabetic 
medication 
≥5.6 mmol/l or 
antidiabetic 
medication 
Other Microalbuminuria - - -  
Modified from Grundy et al. (44). Abbreviations: AHA/NHLBI = an American Heart Association/National 
Heart, Lung, and Blood Institute Scientific Statement (44); BMI = body mass index; HDL-C = high-
density lipoprotein cholesterol; IDF = the International Diabetes Federation (53); IFG = impaired 
fasting glucose; IGT = impaired glucose tolerance; JIS = A Joint Interim Statement of the International 
Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood 
Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, 
and International Association for the Study of Obesity (30); NCEP = the National Cholesterol Education 
Program criteria (54); TG = triglycerides; T2DM = type 2 diabetes; WHO = World Health Organization 
(33). 
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Table 2. Summary of the Finnish nutrition recommendations (282) 
 
Food item or nutrient Recommendation 
Vegetables, fruit and berries At least 500 g/day (=5-6 portions/day), which of half are fruit and berries 
and other half roots and non-root vegetables. 
Grain products Prefer whole grain products, e.g. whole grain pasta and rice, whole grain 
bread containing dietary fiber at least 6 g/100 g. 
Recommended amount: approximately 9 portions/day in men and 6 
portions/day in women. (1 portion = 1 dl cooked pasta or rice, 1 slice of 
bread) 
Milk products Choose low-fat or fat-free products (= ≤1% fat in milk, sour milk or yogurt, 
≤17% fat in cheese). 
Recommended amount: 5 – 6 dl/day fluidy milk products and 2 – 3 slices/day 
cheese. 
Fish, meat and eggs Recommended amount: fish 2–3 times per week, and red meat and 
processed meat products ≤500 g/week. Eggs 2–3/week. 
Choose low-fat and low-salt red meat and processed meat.  
Avoid burnt food. 
Dietary fats Choose soft margarines containing ≥60 % fat on bread. 
Use vegetable oils and vegetable oil based salad dressings with vegetables. 
Choose soft margarines containing ≥60 % fat or vegetable oils for cooking. 
Nuts, almonds and seeds 30 g/day.  
Alcohol ≤20 g/day (=2 portions) in men and ≤10 g/day (=1 portion) in women.  
  
Carbohydrates 45-60 E% 
Added sugar <10 E% 
Fat 25-40 E% 
SFA <10 E% 
MUFA 10-20 E% 
PUFA 5-10 E%, including omega-3 fatty acids ≥1E% 
Protein Adults: 10-20 E% and 1.1-1.3 g/body weight.  
Older adults (≥65 years): 15-20 E% and 1.2-1.4 g/body weight. 
Dietary fiber 25-35 g/day or 3 g/MJ 
  
The importance of dietary pattern as a whole is highlighted 
Abbreviations: MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; SFA = 
saturated fatty acids;  
 
 
Table 3. Recommended dietary changes for Finnish adults to improve energy balance and health (282) 
 
Increase Change Decrease 
Vegetables 
Legumes (peas, beans, 
lentils) 
Refined grain products  -> whole grain 
products 
Meat products 
Red meat 
Berries, fruit  
Fish and other seafood  
Nuts and seed 
Butter, spreads with butter -> vegetable 
oils, soft margarines  
High-fat milk products -> low-fat/fat-
free milk products 
Beverages and foods containing 
added sugar  
Salt  
Alcohol 
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Table 4. Summary of the physical activity guidelines for Americans (110) 
 
Key Guidelines for Adults (age 18-64 years) 
 Avoid inactivity. Some physical activity is better than none. 
 Aerobic physical activity:  
o At least 150 minutes/week at moderate intensity OR 75 minutes/week at vigorous intensity OR 
an equivalent combination of moderate and vigorous activity.  
o For additional and more extensive health benefits, amount should be increased to 300 
minutes/week at moderate intensity OR 150 minutes/week at vigorous intensity OR an 
equivalent combination of moderate and vigorous activity.  
o Should be performed in episodes at least 10 minutes, and spread at least for 3 days.  
 Muscle-strengthening activity:  
o At least 2 days/week at moderate or high intensity, involving all major muscle groups.  
 
Key Guidelines for Older Adults (≥65 years) 
 Guidelines are the same as for adults (see above) 
 When older adults cannot do 150 minutes/week of aerobic exercise due to chronic conditions, they 
should be as physically active as their abilities and conditions allow. 
 Older adults at increased risk of falls should do balance training 3 or more days/week. Examples of 
balance exercises: backward walking, sideways walking, toe walking.  
 
 
Table 5. Examples of different physical activities for adults according to physical activity guidelines for 
Americans (110) 
 
Aerobic exercise at moderate 
intensity 
Aerobic exercise at vigorous 
intensity 
Muscle-strengthening activity 
 Brisk walking (5 km/hour 
or faster but not race-
walking) 
 Water aerobics 
 Bicycling slower than 16 
km/hour 
 Ballroom dancing 
 General gardening 
 Race-walking, jogging, 
running 
 Swimming 
 Tennis 
 Bicycling faster than 16 
km/hour 
 Jumping rope 
 Heavy gardening 
(continuous digging or 
hoeing, with heart rate 
increases) 
 Resistance training 
 Working with resistance 
bands 
 Calisthenics that use body 
weight for resistance (e.g 
push-ups, pull-ups, sit-
ups) 
 Carrying heavy loads 
 Heavy gardening (e.g. 
digging and hoeing) 
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